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Abstract
In this thesis I investigated selective pressures that could shape the ecology and evolution of
the malaria parasite and its mosquito host. I used the rodent malaria parasite Plasmodium
chabaudi, laboratory mice and the lab adapted malaria vector Anopheles stephensi.
Key theory underpinning much of this work is the virulence trade-off hypothesis, where
virulence (harm to host) is thought to be an unavoidable consequence of the parasites effort to
optimise fitness. Implicit in this theory is that virulence is an intrinsic parasite trait, so that a
virulent parasite would be relatively virulent in all host types. Using four genetically distinct
P. chabaudi clones and four distinct host strains I found for the most part, this assumption to
be true; the virulence phenotype of each of the four parasites was the same across the four host
strains tested. I further used these genetically distinct P. chabaudi clones along with candidate
malaria vaccine AMA-l to study 1) vaccine efficacy against single and mixed clone infections
and 2) the potential selective effects of vaccination. I found that vaccination reduced parasite
density in a strain specific manner and that diversity at loci other than the target antigen
influenced vaccine efficacy. In both narve and vaccinated hosts, selection for increased
virulence was observed in mixed genotype infections, but in no case did vaccination enhance
this selective pressure. As Plasmodium evolution is intricately linked to vector population
dynamics, I explored environmental conditions that may influence Anopheles fitness.
Specifically, I investigated whether the amount of food Anopheles parents experienced
influenced the success of their offspring. I found that the food level of both parents and
offspring were important in Anopheles fitness. In particular, daughters from parents reared in
low food conditions produced more eggs that daughters from parents reared in high food
conditions.
In sum, my results indicate that the within-host environment of the malaria parasite can act as
a selective agent. In addition, the environmental conditions experienced by Anopheles larvae
could impact vector population dynamics. Altering the within-host environment of the parasite
or the environment of its vector could dramatically alter the ecology and evolution of the
malaria parasite.
1. General introduction
...
1.1. What is evolutionary biology?
Evolutionary biology is the study of organisms in an evolutionary framework. Central to
evolutionary thinking is the concept of fitness. Fitness is an individual's representation in the
gene pool, or its reproductive success. Each genotype in the population has its own relative
fitness, which is determined by the success of others. Key questions in evolutionary ecology
are therefore concerned with determining what strategies an organism employs to maximize its
fitness.
This differs somewhat from the approach concerned with describing mechanisms behind
phenomena. Ernst Mayr was one of the first to highlight the differences between these two
approaches, noting that functional biologists were mainly concerned with asking 'how' types
of questions, while evolutionary biologists were mainly concerned with asking 'why' types of
questions (Mayr 1961). Using the phenomena of migration in birds, Pianka (1983) extends
Mayr's example to explain that these two approaches differ by providing proximate and
ultimate reasons behind events. For a physiologist he notes that migration may be due to
decreasing day length (photoperiod) causing birds to take flight. In contrast, for the
evolutionary biologist, the explanation for migration may be that the reduced winter mortality
of migratory birds increased the number of their offspring compared to non-migratory birds.
Over a long period of time, this results in the selection for migratory behaviour due to
differential reproductive success. The physiologist's answer describes the mechanism,
whereas the evolutionary ecologist describes a 'strategy'. These two approaches are not
mutually exclusive and modern ecologists incorporate both mechanism and adaptation (e.g.
Stearns 1999; Thierry 2005; Read & Clark 2(06)
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The application of this approach can traditionally be seen in fields including biodiversity and
ecology, behaviour and social evolution, and life history evolution. These fields are largely
concerned with understanding the forces that generate and maintain the high level of diversity
we see in life. The field of biodiversity and ecology examines this variation from the
molecular through to the ecosystem level. Behaviours including co-operation, conflict,
commensalism and parasitism are the realm of behavioural evolutionary biologist. Life history
evolution is concerned with the allocation of resources to growth, survival and reproduction.
More recently, this approach has been extended into the areas of health and disease with the
emergence of the field of 'Darwinian medicine'. This approach uses the principles of
evolution to explain the basis of disease (e.g. Williams & Nesse 1991; Steams 1999; Steams
& Ebert 2001). Gaining an understanding of why parasites harm their hosts (virulence) has
been greatly aided by this approach. Three broad frameworks for explaining virulence have
been established; these being that virulence is coincidental, virulence is a parasite adaptation
and lastly coevolutionary interactions determine virulence (Steams 1999). Using infection
with Plasmodium (the disease causing agent of malaria) as an example, the morbidity and
mortality associated with a malaria infection is believed to arise as a correlated side effect of a
fitness enhancing trait (Mackinnon & Read 2004b). For example, the anaemia associated with
severe disease is a side effect of transmission enhancing asexual parasite multiplication.
Ultimate explanations of virulence can differ from the proximate explanations of virulence.
One such proximate explanation of virulence is that it is caused by rosetting; the process
where infected red blood cells adhere to uninfected red blood cells, cause obstructions and
tissue damage leading to severe disease (e.g. Rowe et al. 2002; Sherman et al. 2003;
Kirchgatter & Del Portillo 2005).
2
Virulence is not the only malaria parasite trait or consequence of infection that evolutionary
...
thinking has been applied to. It has been suggested that either adaptively or coincidentally,
observed sex ratios, host topor and host anaemia could all be fitness enhancing traits
(reviewed by Paul et a1. 2003). For example, evidence suggests that varied sex allocation in
malaria parasites is an adaptive trait to enhance transmission (e.g. Shutler & Read 1998; Paul
et a1.2002a; Paul et al. 2oo2b; West et a1.2002; Reece et al. 2(05). Specifically, the change in
sex ratio from female bias to approximately 50:50 in immune environments, could increase the
probability that male gametes encounter females (Reece & Read 2000; Paul et a1.2oo2a; West
et a1. 2002). Manipulation of mosquito behaviour could also enhance parasite fitness.
Increasing vector probing, altering vector resources and increasing vector longevity, may all
be fitness enhancing mechanisms that increase parasite fitness by ensuring increased
transmission from one host to the next (Poulin 1994; Hurd et a1. 1995; Koella et a1. 1998;
Koella 2005).
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1.2. Predictions and the trade-off model
...
An advantage of using an evolutionary approach is the predictive powers that evolutionary
theory can bestow. In the case of malaria, a theoretical basis has been used to predict selective
pressures that may lead to the evolution of virulence, as well as factors maintaining virulence
in a population. Central to this has been the use of the trade-off model where virulence is an
unavoidable consequence of the parasite's effort to optimise its fitness. Parasites require
extensive host exploitation to obtain transmission to the next host, but at the same time this
exploitation increases the probability that the parasite will kill the host (Anderson & May
1982; Sasaki & Iwasa 1991; Antia et al. 1994; Ebert & Herre 1996; Read et al. 2(02). By this
logic, parasites that replicate too slowly will be cleared by the host before they reach maximal
transmission (Antia et al. 1994), and parasites that replicate too quickly will not reach
maximal transmission if they kill their hosts (Anderson & May 1982; Frank 1996). The result
of this is the selection for parasites with intermediate levels of virulence, so that they are
virulent enough to obtain transmission, but not so virulent that they kill their hosts before this
occurs.
In infections consisting of more than one genetically distinct pathogen lineage, it has been
suggested that increased virulence could evolve due to within-host competition (Levin &
Pimentel 1981; Bremermann & Pickering 1983; Ewald 1983; Bonhoeffer & Nowak 1994;
Nowak & May 1994; van Baalen & Sabelis 1995; Frank 1996; Mosquera & Adler 1998; Fox
et al. 2004). In this situation prudent parasites suffer from great fitness losses in hosts
simultaneously infected with faster growing (virulent parasite). This is because virulent
parasites kill the hosts before prudent parasites have realised their fitness potential. Even
. though hosts death also reduces the fitness of virulent parasites, prudent parasites suffer
disproportionately and are eliminated by natural selection. The fitness benefit of virulence is
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enhanced transmission; by extracting more resources from the host (i.e. red blood cells), the
parasite is able to make more transmissible forms. This process is commonly known as the
tragedy of the commons (Hardin 1968). Alternatively, pathogens could compete in different
ways, such that within-host competition does not result in increased virulence (Chao et al.
2000; Brown et al. 2002; Schjorring & Koella 2003; West & Buckling 2(03).
1.3. Selection on malaria parasites
1.3.1. The Plasmodium genus
Four Plasmodium species infect humans: P. Jalciparum, P. malaria, P. ovale, and P. vivax. P
Jalciparum is generally considered the more severe human malaria, with the majority of
malaria-associated mortality due to this species. Many more Plasmodium species infect
reptiles, birds and other mammals. Experimentally, many of these have been used as models
for human malaria, either in their natural host or laboratory adapted hosts. The major rodent
malaria model systems are P. berghei, P. chabaudi and P. yoelii in laboratory mice.
1.3.2. Malaria intervention strategies
Malaria intervention strategies are usually designed to act against either the replicating stages
or the transmission stages of the malaria parasite. Intervention strategies designed against the
replicating asexual stage, which include most anti-malarial drugs and potential vaccines, are
aimed at easing the suffering of an individual by reducing the parasite density of their
infection. In contrast, transmission blocking intervention strategies, including vector control
programs, some types of vaccines and bednets, aim to reduce the transmission of malaria
without any direct benefit to an infected individual and thus are commonly called
. interventions for the common good (Kaslow 1997; Carter et al. 2000; Tsuboi et al. 2(03).
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From a biomedical perspective an ideal intervention strategy would be one that reduced the
morbidity and mortality the host. However, from an evolutionary perspective an ideal strategy
would reduce the transmission of the parasite to a level where it was unable to be maintained.
In epidemiological terminology, the average number of new infections resulting from an
established infection is its RO (reproductive number). For the successful eradication of any
infection the ROmust be reduced to below 1, so that no new infections are established from an
existing one.
1.3.3. Potential selective effects of vaccination
Current efforts to develop a malaria vaccine are focused on either the pre-erythrocytic stage,
the asexual blood stages (anti-replication) or the transmission stage of the malaria parasite
(most recently reviewed in Targett 2005; Chiang et al. 2006; Hill 2006; Reed et al. 2006).
Potential anti-replication vaccines include MSP-l and AMA-l antigens and are primarily
aimed at reducing the parasite density within an individual. If this reduction is incomplete,
hosts could still become infected by and transmit parasites. Theoretically, a side-effect of this
type of scenario could include the evolution of increased virulence in the parasite population
(Gandon et al. 2001). Conventional wisdom suggests that excessively virulent parasites kill
their hosts and therefore themselves. Even in situations where mortality is low, it is the risk of
mortality that is in trade-off against the benefits of virulence (taken to be parasite transmission
success). When virulence is intrinsically linked with parasite density and transmission success,
it is feasible to expect lesser virulent parasites to be removed from the parasite population
more quickly than virulent types. Critically, this selection depends on the type of vaccine. Anti
infection and transmission - blocking vaccines will not favour increased virulence, as the costs
associated with increased virulence are maintained (Read et al. 2004). The combination of
antigens from different stages of the malaria life cycle is one approach that has the potential to
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limit selection for increased virulence. Including an asexual antigen in a vaccine targeting
sporozoites, hepatocytes or transmission stages, a second line of defence would be provided
and the spread of selected parasites could be reduced (Richie & Saul 2002).
Genetic diversity among and within the Plasmodium species has been a key concern in the
development of an effective malaria vaccine. This concern stems from experimental evidence
showing antibody specificity to candidate vaccine antigens in human serum, as well as the
specificity of the immune response to candidate vaccine antigens in animal models (Crewther
et al. 1996; Hodder et al. 2001; Mota et al. 2001; O'Donnell et al. 2001; Ekala et al. 2002;
Healer et al. 2004; Polley et al. 2004; Cortes et al. 2005). In both single and mixed genotype
malaria infections, the specificity of vaccine could alter the subset of genotypes circulating in
a population. Considering mixed infections only, specificity could also alter the multiplicity of
an infection, as well the competitive interactions between parasites.
Malaria infections often consist of more than one genotype, arising from the injection of a
diverse inocula or from the injection of genotype before an existing one is cleared (Babiker et
al. 1991; Babiker et al. 1999a; Paul et al. 1999; Smith et al. 1999; Tanner et al. 1999;
Engelbrecht et al. 2000; Bruce & Day 2002; Henning et al. 2004). As the host constitutes an
environment of limiting resources as well as an environment under immune attack, it also
seems likely that these genotypes are in competition. Indirect evidence for this exists in P.
Jalciparum infections (Daubersies et al. 1996; Mercereau-Puijalon 1996; Arnot 1998; Smith
et al. 1999; Bruce et al. 2000), and direct experimental evidence of competitive interactions in
the rodent malaria model P. chabaudi have been demonstrated across a range of host strains,
parasite genotypes, multiplicity and parasite dose (Snounou et al. 1992; Taylor et al. 1997; de
Roode et al. 2003; de Roode et al. 2004a; de Roode et al. 2004b; de Roode et al. 2005a; de
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Roode et al. 2005b; Bell et al. 2006; Raberg et al. 2006). From the above experiments the
...
general phenomenon has emerged that in P. chabaudi, virulent genotypes are competitively
superior to less virulent genotypes in mixed infections (de Roode et al. 2005b; Bell et al.
2006). This is consistent with the assumptions of many models of the evolution of virulence
(Levin & Pimentel 1981; Bremermann & Pickering 1983; Ewald 1983; Bonhoeffer & Nowak
1994; Nowak & May 1994; van Baalen & Sabelis 1995; Frank 1996; Mosquera & Adler 1998;
Fox et al. 2004); so that all else being equal mixed infections create a selective environment
favouring more virulent strains than favoured in single clone infections.
To date, the study of competition in the rodent model has been restricted to nai've hosts.
However, many people in malaria endemic areas are semi-immune and central to all
vaccination programmes is the induction of immunity. Theoretically, it seems feasible that
vaccine induced immunity could lead to either an increase or decrease in the level of
competition. In practice, this depends on the mechanisms mediating competition. For example,
if competition is largely resource based and anti-replication vaccines reduce parasite densities
to levels where resources are not limiting, the level of competition may be relaxed. If
competition is immune mediated and the anti-replicating vaccine is largely genotype specific
against the more competitive genotype, competition could be relaxed. However, if competition
is mediated via a transcending immune response, vaccine induced non-specific immunity may
increase the competitiveness of an infection, leading to the preferential removal of the less
competitive clone (Raberg et al. 2006)
Evidence of selective effects was recently observed in the clinical trial of an asexual blood
stage vaccine, combination B. In this trial selection for infections that differed from the
vaccine type occurred (Genton et al. 2002). The combination B vaccine comprises of the
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merozoite surface protein (MSP-l), the 3D7 allele of MSP-2 and the ring infected erythrocyte
surface antigen (RESA). During the follow up period of the vaccine trial, the prevalence of the
3D7 allele but not the alternate FC27 allele was reduced. As the FC27 type allele is also
considered to result in more virulent infections (Engelbrecht et al. 1995), it is actually unclear
as to whether vaccine escape was due to genetic polymorphism (as is generally assumed) or
whether intrinsic parasite virulence played a role. Either way, the outcome of the trial was the
same and the concerns regarding the selective effects of vaccination are warranted.
1.4. Selection of Anopheles mosquitoes
There are approximately 3,500 species of mosquitoes grouped into 41 genera. Of these female
anopheles mosquitoes (Diptera: Culicidae) are responsible for the transmission of all of the
malarias 1. Between, 40-70 species are considered be transmit malaria, with Anopheles
gambiae and Anopheles Junestus transmitting the more severe species of malaria Plasmodium
Jalciparum.
104.1. Mosquito intervention strategies
To date, many mosquito control strategies have involved targeting the larval and adult stages
of the mosquito life cycle stages, with the common aim of decreasing the vector population
density and disease transmission (Shiff 2002; Pates & Curtis 2005). In particular, the process
of environmental management has the aim of reducing the number of breeding sites and the
vector population by disrupting larval breeding sites through the use of oil spraying and water
drainage (Phillips 2001; Bond et al. 2004; De Castro et al. 2004; Fillinger et al. 2004).
Traditional control strategies involving the application of insecticides to the insides of
. dwellings specifically targets the resting adult vectors (McCarroll et al. 2000; Killeen et al.
I http://www.cdc.govlMalarialbio!ogy/mosquitoi
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2002; Brey 2003) and, advances in this area have lead to the proposed use fungal biopesticides
rather than chemical insecticides (Scholte et al. 2003; Blanford et al. 2005; Kanzok & Jacobs-
Lorena 2(06).
1.4.2. Mosquito fitness
Consisting of four distinct stages, Anopheles mosquitoes develop from eggs, through aquatic
larval and pupae stages and finally emerge as full size adults. During each of these four life
cycle stages the overall fitness of the mosquito is determined. Key life history traits during
these stages include emergence time, size, fecundity and survival (Clements 1992; CharIwood
2003; Depinay et al. 2004). For both sexes, a reduced egg-to-adult emergence time is
beneficial as it reduces generation time. Males with a shorter aquatic stage may also be at a
further advantage if they emerge before females who become refractory to further mating. In
contrast, a longer development time may increase body size, which is sometimes thought to be
beneficial in mating success. For females, a classic trade-off between short development time
and large adult size occurs, due to the positive correlation between size and fecundity
(Clements 1992; Clements 1999).
These fitness components are influenced by genetic background, environmental conditions
and interactions between the two. Key environmental factors include temperature, moisture
and nutrition competition (Lyimo et al. 1992; Suwanchaichinda & Paskewitz 1998; Tun-Lin et
al. 2(00). Another environmental factor which is increasingly recognised to have a profound
impact on individual success is the environmental conditions experienced by parents
(Kirkpatrick & Lande 1989; Bernardo 1996; Rossiter 1996; Mousseau & Fox 1998; Wolf et al.
1998). Such trans generational effects are a common form of phenotypic plasticity where an
individual's characteristics are influenced by the environment or condition of its parent. If
10
present, mosquito control methods resulting in environmental modification of larval habitat, as
...
well as strategies involving the large scale rearing and release of genetically modified or
sterile males may benefit from an increased understanding of how parent and offspring larval
rearing conditions interact to alter mosquito ecology and evolution.
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1.5. Experimental aims
In this thesis I use an evolutionary approach to explore factors shaping the ecology and
evolution of Plasmodium and Anopheles, using the rodent malaria P. chabaudi and laboratory
reared A. stephensi. Each chapter is been written as a stand alone paper, with its own
introduction. However, a summary of the experimental aims are as follows:
In chapter 2, I explore the applicability of evolution of virulence trade-off theory to the rodent
malaria model system P. chabaudi.
In chapters 3 and 4, I investigate the potential selective effects of an asexual malaria vaccine
on Plasmodium. Specifically, I ask:
a) How does parasite diversity and virulence influence vaccine efficacy?
b) Is competition increased or alleviated in immune animals?
In chapter 5, I investigate the potential of transgenerational effects to influence Anopheles
population dynamics. Specifically I ask,
Do the larval habitats of Anopheles parents influence the key life history traits of emergence
time, survival, blood meal size and fecundity of their offspring?
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2. Host-by-parasite interactions for virulence and resistance in a
malaria model system.
This chapter has been published as: Grech, K., Watt, K. & Read, A. F. 2006 Host-parasite
interactions for virulence and resistance in a malaria model system. Journal of Evolutionary
Biology (19), 1620-1630.
2.1. Abstract
A rich body of theory on the evolution of virulence (disease severity) attempts to predict the
conditions that cause parasites to harm their hosts, and a central assumption to many of these
models is that virulence of a pathogen strain is stable across a range of host types. In contrast,
a largely non-overlapping body of theory on coevolution assumes that the fitness effects of
parasites on hosts is not stable across host genotype, but instead depends on host genotype by
parasite genotype interactions. If such genetic interactions largely determine virulence, it
becomes difficult to predict the strength and direction of selection on virulence. In this study I
tested for host-by-parasite interactions in a medically relevant vertebrate disease model: the
rodent malaria parasite Plasmodium chabaudi in laboratory mice. I found that parasite and
particularly host main effects explained most of the variance in virulence (anaemia and weight
loss), resistance (parasite burden) and transmission potential. Host-by-parasite interactions
were of limited influence, but nevertheless had significant effects. This raises the possibility
that host heterogeneity may affect the rate of any parasite response to selection on virulence.
This study of rodent malaria is one of the first tests for host-by-parasite interactions in any
vertebrate disease; host-by-parasite interactions typical of those assumed in coevolutionary
models were present, but were by no means pervasive.
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2.2. Introduction
Pathogen evolution can be a key obstacle in the development of effective disease control
programmes. Drug resistance is the most obvious example (e.g. Nkengasong et al. 2004;
Talisuna et al. 2004; e.g. Olliaro 2005; Tripathi et al. 2005), but the possibility that pathogen
virulence (here defined as harm to the host following infection) could also evolve is beginning
to attract the attention of evolutionary biologists (Ewald 1994; Gandon et al. 2001; Dieckmann
et al. 2002). For the most part, virulence evolution has been studied using parasite-centred
models, where the direction of selection acting on parasite-encoded virulence is modelled as
an optimality problem (e.g. Bremermann & Pickering 1983; May & Anderson 1983; Frank
1996; Andre et al. 2003; Choo et al. 2003; Day & Proulx 2004). This has led to ideas of
virulence management (Dieckmann et al. 2002) and specific predictions about, for instance,
public health strategies which could prompt the evolution of benign parasites (Ewald 1994) or
create the conditions which would favour more virulent pathogens (Gandon et al. 2001).
This parasite-centric approach to virulence evolution, which has attracted some controversy
(e.g. Soubeyrand & Plotkin 2002; Ebert & Bull 2003), coexists uneasily alongside a largely
independent body of work on host-parasite coevolution which emphasises that parasite and
host genotypes together determine virulence (e.g. Ebert & Hamilton 1996; Woolhouse et al.
2002). Part of the unease is semantic: the term virulence is used in some of the coevolutionary
literature (e.g. gene-for-gene and matching allele models) to mean the ability to infect a host,
rather than as harm per se. However, even with these models and certainly for more general
notions of on-going host-parasite arms races, the harm done to hosts following infection (the
definition of virulence I use here) is a key source of selection. A more important difference
. between the two literatures is the nature of genetic control of disease severity. Coevolutionary
arguments necessarily posit that harm is determined by interactions between parasite and host
14
genotypes, with particular strains being harmful in some host genotypes and benign on others .
...
The specificity of these host-parasite interactions provides the genetic basis of alleged ongoing
coevolutionary dynamics. The evolution of virulence literature ignores such genotype-by-
genotype specificity and emphasises instead parasite encoded virulence.
These parasite-centric and coevolutionary views, which emphasize respectively, parasite main
effects and host genotype by parasite genotype interactions, are not necessarily mutually
exclusive. Optimality models typically assume that a given pathogen strain has a virulence
phenotype that is stable across a range of host genotypes (e.g. Andre et al. 2003; Choo et al.
2003; Day & Proulx 2004; Lambrechts et al. 2006a) (Figure 2.1a). Assuming that virulence
and transmission are positively correlated, as is often the case (e.g. Lipsitch & Moxon 1997;
Mackinnon & Read 1999a), the transmission success and virulence of each parasite genotype
could still vary, depending on for example, host genetic background or immune status.
However, the relative impact of the different pathogen strains remains constant across host
types (Figure 2.1b). In contrast, a variety of non-additive (host) genotype x (parasite) genotype
interactions is also possible. In some cases, some parasite strains may cause more virulence
than others, with this effect more pronounced in certain host genotypes than others (Figure
2.1c). Host-by-parasite interactions in coevolutionary models are such that a pathogen strain
that causes high virulence in a particular host genotype could actually be the more benign
strain in another genotype, commonly known as crossing of reaction norms (Figure 2.1d)
If such genotype-by-genotype interactions are widespread. it becomes increasingly difficult to
predict evolutionary responses to selection on pathogen-encoded virulence determinants. If
virulence in nature is largely a consequence of the genotype-by-genotype specificity of host-
parasite interactions, it is difficult to imagine that parasite-centred optimality models of
15
pathogen virulence could provide much insight into evolutionary trajectories. Precisely
analogous arguments can be made for resistance (host ability to control parasites). If genetic
variation for resistance is mainly due to a main effect of host, then resistance evolution can be
modelled as a simple host-centred optimality problem. If control of parasites is predominately
a consequence of host -by-parasite interactions as in Figure 2.1d, it can not.
There has been some work on specificity in host-pathogen interactions for plant and
invertebrate hosts (e.g. Carius et al. 2001; Ferrari & Godfray 2003), but almost none on
medically relevant diseases in vertebrates; most studies have concentrated on either host
variation (e.g. Abel & Dessein 1997; Amarante & Oliveira-Sequeira 2002; Mackinnon et al.
2002; de Roode et al. 2004b), or pathogen variation (Appleford & Smith 1997; Macedo &
Pena 1998; Mackinnon et al. 2005), but not both. Yet, in both clinical and model malaria, it
has long been recognised that both host factors (e.g. Stevenson et al. 1982; Burt 1999; Troye-
Blomberg 2002) and parasite factors (e.g. Arley et al. 2001; Read & Taylor 2001; Mackinnon
& Read 2004b; Read et al. 2004; Kirchgatter & Del Portillo 2005) can affect disease outcome.
Indeed, studies on human malaria have given us some of the best examples of host factors
associated with resistance/susceptibility, including sickle cell anaemia (e.g. Williams et al.
2005) and particular MHC alleles (e.g. Segal & Hill 2003). Likewise, parasite-encoded
phenotypes such as cytoadherence (Sherman et al. 2003) and rosetting (e.g. Rowe et al. 2002)
are recognised to contribute to malaria severity. What is fundamentally lacking is any real
understanding of the interactions between these host and parasite effects.
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To address this, I performed a fully cross-factored experiment, using four parasite genotypes
of Plasmodium chabaudi and four inbred mouse strains as hosts. I measured the virulence
(severity) of the subsequent infections as well as within-host parasite abundance, which is a
standard measure of host resistance (Fortin et al. 2001). So far as I am aware, this is one of
the few times host-by-parasite interactions have been tested for in a medically relevant
vertebrate system (see also Mackinnon et al. 2002). These results showed a combination of all
possible scenarios (Figure 2.1a-d), depending on the measure of virulence or parasite success.
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A schematic representation of host, parasite and host-by-parasite interaction effects, showing (a) a parasite main
effect only, (b) additive parasite and host main effects, (c) non-additive host and parasite interactions without
crossing reaction norms where pathogen differences are more apparent in one of the host genotypes and (d) host-
by-parasite models.
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2.3. Materials and methods
2.3.1. Parasites and Hosts
Plasmodium chabaudi isolates were collected from Thamnomys rutilans in the Central
African Republic in 1969 and 1970. Genetically distinct parasite clones (Carter 1978),
representing a range of virulence levels were then obtained from the isolates as described in
Mackinnon and Read (1999). These clones are maintained as frozen stabilates, with the
precise point in the clonal histories from which they come denoted with a subscript code.
Below, I refer to them only using their letter codes for simplicity, but the clones were as
follows: AJ4607, AS1I918, CWS12, and ERs770
Hosts were female mice, of inbred strains, CBAlCaOlaHsd, DBAl201aHsd, C57BU6JolaHsd
and NIH (Harlan England) aged 6-8 weeks. These hosts were chosen as they differ at the
MHC (Lyon & Searle 1989) and control densities of P. chabaudi (clone AS) to varying
degrees and are therefore known as more or less 'resistant' strains (Stevenson et aI. 1982;
Stevenson & Skamene 1986). Mice were fed on 41B maintenance diet (Harlan England) and
drinking water was supplemented with 0.05% para-amino benzoic acid to aid parasite growth.
ArtificiaIlight was provided from 05:30 to 17:30hrs. From hereon, hosts will be referred to as
C57, CBA, DBA and NIH, with the term 'strain' used to denote mouse genotype and 'clone'
to refer to parasite genotype.
2.3.2. Experimental design and inoculation of mice with parasites
The experiment was conducted in two replicate blocks four weeks apart. Both blocks
consisted of 16 infected treatment groups (four clones x four strains), each with three replicate
.mice. Infections were initiated with an intra-peritoneal injection of 1x106 parasitised red blood
cells. Inoculations were prepared by diluting infected blood from donor mice in a calf-serum
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solution (50% heat inactivated Calf Serum; 50% Ringer solution [27mM KCL, 27mMCaCh
...
and 0.15 M NaCl], with 20 units of heparin Iml). Control mice received the same volume of
uninfected red blood cells in calf-serum solution. Mice were sampled daily between days 3
and 21 post injection. Sampling involved determining mouse weight to an accuracy of O.lg
and red blood cell density using flow cytometery (Beckman Coulter). Thin smears from tail
blood were fixed in methanol and stained in Giemsa to determine levels of asexual
parasitaemia and gametocytaemia using microscopy.
2.3.3. Trait definition and statistical analysis
To determine the total number of asexual parasites and gametocytes present during the
infection, I calculated the area under the curves for parasite and gametocyte density through
time. Parasite densities and gametocyte densities are the products of the parasitaemia or
gametocytaemia multiplied by red blood cell density. All density data were transformed using
[loglO (density +10)] to normalise the residuals. Only mice surviving until the end of the
experiment were used in analysis of these data. I also determined the maximum parasite
density as well as the number of days taken to reach the maximum. As all mice that died had
declining parasite densities when they died, they were included in the maximum parasite
density analysis. Three mice had standard asexual infection profiles, but produced no
detectable gametocytes. As we had never previously observed infections with no gametocytes
and as these three zero values generated enormous residuals the mice were removed from the
gametocyte analysis so as to not violate statistical assumptions.
For measures of virulence Idetermined the 'minimum weight' and the 'minimum red blood
cell density' reached during the experiment. Most models of virulence focus on the risk of
death as a virulence measure, for which minimum weight and minimum red blood cell density
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are correlates (Mackinnon & Read 2004b). It was assumed that all mice reach these minima
prior to death. Therefore, even mice that died were included in the virulence analysis. Initial
weight and initial red blood cell density were included as covariates where applicable and the
density data was transformed using [loglO]to normalise the residuals.
I investigated the effect of host strain (four levels), parasite clone (four levels) and a host-by-
parasite interaction on these variables using General Linear Models (Minitab 14, Minitab Inc.,
State College, PA, USA) or Proportional Hazards (JMP in 5.1, SAS Institute Inc., USA). For
all our models I first fitted the maximal models including the main effects of host strain,
parasite genotype and experimental block, a covariate (when relevant) and all two and three-
way interactions. I then minimized the models by removing non-significant terms (p > 0.05),
beginning with the highest-level interaction. As 'block' main effects are of little biological
interest in their own right, I reported them only if they interacted significantly with the host-
by-parasite interaction. I also investigated the relationships between asexual parasites,
transmission stages and virulence, which are key relationships in evolutionary theory (Frank
1996), with regression analysis of the variables of 'total parasite density', 'total gametocyte
density' and 'weight loss'.
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2.4. Results
...
2.4.1. Parasite kinetics
The kinetics of parasite and gametocyte densities are illustrated in Figure 2.2. and virulence in
Figure 2.3. Within all host strains, parasites increased in density followed by a dramatic
reduction and then recrudescence (Figure 2.2.). Patterns of virulence were largely the inverse
of the parasite densities, with an initial reduction in both weight and red blood cell density,
followed by either a full or partial return to pre-infection levels (Figures 2.3). During the
experiment, nine out of 96 mice died during the course of infection. Five of these hosts were
of the NIH strain, with 3 infected with the AJ parasite clone and two with ER clone. Three
further deaths occurred in CBA hosts with two of these hosts infected with AS and the other
with the AJ. One further death occurred in host strain DBA with an AJ clone infection.
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Figure 2.2. Parasite (a) and gametocyte (b) densities through time, for each of the four Plasmodium chabaudi..
clones in each of the four host strains tested. Each line represents the mean parasite density for each parasite
clone (AJ, AS, CW or ER) in each host strain (C57, CBA, DBA and NIH) with the associated standard error,
averaged across two experiments. Each data point is an average up to six mice. Note different y-axis for
gametocyte densities, which usually constitute <1% of all parasite.
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Figure 2.3. Daily weight change (a) and red blood cell density change (b), from pre-inoculation values
(horizontal lines). Each line represents the mean for each parasite clone in each host strain. Each data point is an
average of up to six mice.
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2.4.2 Parasite dynamics
Total parasite density in an infection was significantly affected by host and parasite main
effects, as well as by a host-by-parasite interaction (Figure 2.4; Table 2.1a; p=0.029).
However, across both blocks, clone AJ in host strain CBA displayed unusual dynamics by
reaching its peak parasite density late in the infection (Figure 2.2). On its removal, the
interaction term was no longer significant (Table 2.1b; p=0.37). In this and all further
analyses of parasite dynamics, if any other single group was removed, the host-by-parasite
-
interaction remained significant or marginally significant. I therefore report all results with
and without the AJ-CBA treatment group (Table 2.1).
Within each host strain, a clone effect on parasite density could be detected only in strains
CBA and DBA (F3.16=11.6,p<O.OI; F3.16=3.5,p=0.037 respectively; C57: F3.16=1.9,p=O.I6;
NIH: F3. 16=0.97, p=0.43). In host strain CBA, total parasite densities of parasite clones AJ
and ER were lower than densities of AS and CW, while in host strain DBA, the total parasite
density of clone AJ was greater than the others.
The average time taken to reach the maximum parasite density ranged between 5 - 11 days.
This timing was influenced by main effects and a host-by-parasite interaction (Figure 2.4b, p=
0.024). On the removal of the AJ-CBA treatment group, the timing of the peak parasite
density was not affected by host or parasite main effects or an interaction (host: p=0.47;
parasite: p=0.08; interaction: p=0.09). Total gametocyte density was also determined by a
host-by-parasite interaction (Figure 2.4c; Table 2.1a; p=O.04). Removing the AJ-CBA
treatment group the interaction was no longer significant (Table 2.1b; p=O.29). An effect of
parasite clone on gametocyte density was detected within all host strains (C57: F3. 17=7.8,
p<O.OI; CBA: F3.16=72.8,p<O.OOl;DBA: F3.IS=6.7, p<O.OOl;NIH: F3.14=0.1.9, p=O.025).
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Figure 2.4. Host-by-parasite interaction plots in resistance and transmission potential, demonstrated by the (a)
least square means of the total parasite density (b) mean day of peak parasite density and (c) least square means
of the total gametocyte density, for each parasite clone (Al, AS, CW or ER) in each host strain (C57, CBA, DBA
and NIH) with the associated standard error.
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Table 2.1 (a) The proportion of variance explained in resistance, transmission potential and virulence, by the
main factors of parasite clone and host strain, as well as the host-by-parasite interaction in a Plasmodium
chabaudi infection (b) The proportion of variance explained in resistance, transmission potential and virulence as
above, excluding the parasite clone AI in host strain CBA, which displayed unusual parasite kinetics. Note that
the percentage explained by each factor does not always add to 100% as some of the variance is explained by
other terms in the model. * p = <0.05; **p=<0.005; ***p<O.OOOI;nsenonsignificant.
Parasite .. Host Host"Parasite
(a)
Total Parasite Density F3,111=5.4; 3.4% -- F3,111=135.1; 84.1% --- Fe,lII=2.3; 4.2% -
Total Gametocyte Density F3,M=36.4; 36.4% --- F3,M= 29.9; 30.2% --- Fe,M=2.1; 6.0% -
Weight F3,71= 4.8; 3.9% -- F3,71=96.3; 78.4% --- Fe,71=3.7; 8.9% --
Red Blood Cell Densltv F3,n= 3.9' 22,3% - F3,n= 7.0' 39.7% -- Fe.n= 2.0' 34.2% -
Parasite Host Host-Parasite
(b)
Total Parasite Density F3,84= 6.6; 4.4% -- F3,84=13O.7; 87.5% --- Fe,M=1.1; 1.8% no
Total Gametocyte Density F3,M=31.2; 47.4% --- F3,ee=32.3; 49.4% --- Fue=0.49; 2.1% no
Weight F3,e7= 2.5; 5.0% - F3,e7=99.2; 80.4% --- Fe,e7=3.4; 7.4% --
Red Blood Cell Density F3.n= 3,9' 17.2% -- F3.78= 11.6' 22.0% --- Fe.ee=0.5· 7.8% no
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2.4.3 Virulence
...
Some of the virulence variation was due to host-by-parasite interactions (Table la, Figure 2.5;
minimum weight; p<O.OI, minimum red blood cell density; p=0.048). As with parasite
densities, exclusion of the AJ-CBA treatment group resulted in a non-significant host-by-
parasite interaction term for minimum red blood cell density (Table lb; p=0.83), and with the
removal of any other group the interaction still remained significant or marginally significant.
In contrast, no single group accounted for the host-by-parasite interaction in minimum weight,
which remained significant despite the removal of clone the AJ-CBA treatment group (Table
lb; p<O.OI). Within each host strain, the effect of parasite clone on the minimum weight
reached during the infection could only be detected in strains CS7 and NIH (F3. 16=4.9,
p=0.012; F3.16=8.4,p=O.OOIrespectively; CBA: F3. 18=2.0,p=0.14; DBA: F3.18=0.46,p=0.7).
In both of these host strains, the parasite clones ranked from least to most virulent were: AS,
CW, ER and AJ. Parasite differences in the minimum red blood cell density could be detected
in host strains CS7 and DBA (F3. 16=4.4,p=0.019; F3. 17=3.2,p=O.049 respectively; CBA: F3.
18=1.7,p=0.19; NIH: F3.17=1.3,p=0.30) with the same rank order.
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as above.
31
2.4.3 Relationships between traits
...
In parasite-centred models of virulence evolution, it is frequently assumed that parasite
densities and/or transmission will be positively correlated with virulence (Frank 1996). I
found that total gametocyte density was positively correlated with total parasite density
(Figure 2.6a; Ft, 74=24.4, p<O.OOl), and was not influenced by a host-by-parasite interaction
(host*parasite *total parasite density; F9,43=0.43, p=0.9). Likewise, total parasite density was
correlated with maximum weight loss in a linear positive manner (Figure 2.6b; Ft, 74=32.8,
-
p<O.OOl), with no effect of an interaction (host*parasite*total parasite density; F9,43= 0.88,
p=O.S). For both of these relationships, the 2-way interactions of host* total parasite density
and parasite*total parasite density were non significant. There was no relationship between
gametocyte density and weight loss (FigureSc; Ft, 74=1.0, p=0.31) nor any host-by-parasite by
weightloss interaction (host*parasite*weight loss; F9,43= 1.0, p=0.39). The 2-way interactions
of host*weight loss and parasite*weight loss, were significant predictors of gametocyte
density (F9,52= 3.4, p=0.02; F9,52= 3.1, p=0.03), so that relationships between virulence and
transmission potential depend on both the host strain and the parasite clone, but not host-by-
parasite interactions.
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2.5 Discussion
In this study, I used the rodent malaria model system of Plasmodium chabaudi in laboratory
mice to determine if host-by-parasite interactions were involved in determining the virulence,
resistance and transmission potential of rodent malaria infections. The availability of a range
P. chabaudi clones and a range of distinct hosts provided us with a unique opportunity to test
biological assumptions implicit in both evolution of virulence and coevolutionary theoretical
models in a medically relevant animal model.
I detected host genotype-by parasite genotype interactions, but found that they were generally
of small effect size, primarily arising from the effects of one parasite clone in one particular
host strain (Table 2.la vs. 2.lb). Even with the inclusion of this treatment group, the
interaction term explained only 4.2% and 6.0% of the variance in the total parasite density and
gametocyte density respectively (Table la). For virulence, host-by-parasite interactions
explained more of the variance: for minimum weight, the interaction explained 8.9% of the
variance, while for red blood cell density, it explained 34.2% of the variance. Again though,
much of this was due to one particular host-parasite combination (Table 2.1a vs. 2.1b).
Overall, the interactions detected showed patterns akin to both types of interactions (Figures
2.1c and 2.1d). Parasite clone effects were at times more pronounced in certain host strains
than in others, while crossing of reaction norms were also observed (Figures 2.4 and 2.5). The
limited size of our interaction effects, however, clearly inhibits our ability to make precise
comparisons to the simplified scenarios of Figure 2.1.
Experimental tests of virulence optimality theory and estimates of genotype-by-genotype
interactions are very rare in vertebrate disease systems. In animal models of malaria, most
work has been concentrated on different parasites in a single host genotype (Jarra & Brown
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1989; Mackinnon & Read 1999a; Paul et al. 2004; de Roode et al. 2005b) ,or a single parasite
line in different host genotypes (e.g. Stevenson et al. 1982; Fortin et al. 2001; de Roode et al.
2004b). I am aware of only two other malaria studies that simultaneously examined both host
and parasite genotypes; neither found host-parasite interaction and both found, as we did, that
host genotype was a relatively more important determinant of both resistance and virulence
than was parasite genotype. In the first study, three different mouse strains were infection with
either a low virulence clone of P. chabaudi or a more virulent line derived from it by serial
-
passage. For these two highly related lines, there was no evidence of host-parasite interactions
for any of the variables examined (Mackinnon et al. 2002). The other study involved two
unrelated clones in two strains of mice and again found no host-parasite interactions for
virulence (de Roode et al. 2004b). The four treatment combinations in that experiment were
also present in the experiments I report here and include the AJ-CBA combination we found to
be a marked outlier responsible for most of the host-parasite interactions (Table 2.1, Figure
2.2). In that earlier study, the dynamics of clone AJ in CBA mice was much more in line with
what we found for all of the host-parasite combinations. We have no explanation for the
difference between the studies (I used the same laboratory, same mouse supplier, clonal
lineages, diet, gender and approximate mouse weights), but we do note that the aberrant AJ-
CBA dynamics we report occurred in both of our experimental blocks.
This experiment thus emphasises how the response to selection on parasite virulence could
vary depending on host genotype: virulence variation was detectable in C57 mice but not, for
example, in CBAs. As a consequence, it could be expected that the parasite response to
selection on virulence would be more rapid in C57 mice than CBAs. Genetic and/or
phenotypic host heterogeneity may therefore affect virulence evolution, as predicted by theory
(e.g. Gandon & Michalakis 2000; Gandon et al. 2002; Ganusov et al. 2002). Selection
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experiments involving serial passage of parasites have demonstrated that both naive and semi-
...
immune hosts can select for increased virulence, but passage through semi-immune hosts
causes a more rapid virulence increase (Mackinnon & Read 2004a). These different rates of
evolution could be explained if the expression of virulence differed between the naive and
semi-immune hosts, analogous to the differences I saw between host strains. Together these
experiments highlight that predicting the effects of selection on parasites will require
understanding of how host genotype and/or phenotype affect the expression of virulence.
Determining if semi-immunity affects the expression of virulence variation is not a relatively
simple matter of repeating the experiments here using semi-immune animals. Immunity to
malaria has a strain-specific component (e.g. Martinelli et al. 2005), so that choice of
immunising strain becomes critical. Crucially, though, such experiments would allow us to
determine if host immunity, including immunity generated by vaccination, will enhance the
importance of parasite genotype relative to the effects of host genotype, as the determinant of
virulence and resistance.
The experimental results I report here showed neither that highly specific host-by-parasite
interactions dominated, nor that they were wholly absent. It may be that our choice of host
strains or of parasite clones is unrepresentative of genetic diversity of Plasmodium-host
interactions in the field. If a generality does exist, control strategies may be greatly aided by
the knowledge that either parasite-centred models or coevolutionary models best capture
malaria evolution. Of course, as with our experiments, the real world may involve aspects of
both.
36
3. The impact of genetic diversity in Plasmodium chabaudi AMA-1
on vaccination with AMA-1 protein
3.1. Abstract
The potential for public health interventions to act as agents of selection is increasingly
recognised. In particular, previous studies have shown that malaria anti-replication vaccines
have the potential to select for both vaccine escape mutants and for increased virulence. In this
study, I used a malaria model system of Plasmodium chabaudi in laboratory mice to determine
the effect of parasite genetic diversity. I found that vaccination provided protection from
virulence and that parasite density was reduced in a strain specific manner. Moreover, I found
that diversity at loci other than the target antigen (which could include virulence determinants)
influenced vaccine efficacy.
3.2. Introduction
Genetic diversity between and within Plasmodium species is a key issue for malaria control
programs. Leading vaccine candidate antigens are frequently polymorphic in natural parasite
populations, which may be a hindrance to vaccine efficacy if protection is conferred in a strain
specific manner. One such leading blood stage antigen is the apical merozoite antigen (AMA-
1) (Carvalho et al. 2002; Ballou et al. 2004; Greenwood et al. 2(05). AMA-l is thought to be
involved in red blood cell invasion (Triglia et al. 2000; Mitchell et al. 2004; Healer et al. 2(05)
and is found on the rhoptry of the merozoite (Peterson et al. 1989). Across many Plasmodium
species, AMA-l has been found to lack the sequence repeats and size polymorphisms found in
other blood stage candidate antigens (Marshall et al. 1989; Peterson et al. 1990; Waters et al.
1990; Kocken et al. 2000). What limited variation there is in AMA-l is due to non randomly
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dispersed point mutations (Peterson et al. 1989; Marshall et al. 1996). To date, the most
divergent P. falciparum isolates have been found to differ at 37 nucleotides within the ama-J
gene, resulting in 32 amino acid substitutions (Marshall et al. 1996).
In vitro studies using P. falciparum AMA-l have indicated that these point mutations may be
of immunological importance. In particular, merozoite invasion assays have shown that
antibodies from rabbits immunised with recombinant P. falciparum AMA-l, as well as anti-
AMA-l antibodies from people in Papua New Guinea, inhibit parasite growth in a strain-
specific manner (Hodder et al. 2001). Comparably, sera from animals immunised with the
recombinant AMA-l derived from P. falciparum laboratory clones FVO and 307 showed
greater inhibition of growth against themselves than against each other (Kennedy et al. 2002).
Lastly, transgenic parasite lines that differ only in the hyper-variable region of domain 1 have
also been shown to be inhibited in a specific manner, confirming relevance of polymorphism
within the AMA-l antigen (Healer et al. 2004).
The use of model systems is vital in the pre-clinical development of vaccines, and they have
been used extensively to test delivery systems, adjuvants and immunisation protocols.
However, the use of these models to test vaccine efficacy across a range of parasite genotypes
has yet to be fully exploited. To date, rodent and non-human primate model systems have been
used to determine the efficacy of the AMA-l vaccine mainly against homologous whole
parasite challenge (Deans et al. 1988; Crewther et al. 1996; Collins et al. 1997; Anders et al.
1998; Burns et al. 2003; Burns et al. 2004). In the limited number of studies using
heterologous parasite challenge, mice immunised with recombinant AMA-l derived from
parasite line P. chabaudi adami [OS] were not protected against parasite line P. chabaudi
adami [556KA] (Crewther et al., 1996; Anders et al., 1998). To our knowledge, no further
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heterologous in vivo experiments have been reported In the testing of AMA-l vaccine
...
efficacy.
The consequence of a vaccine that imposes selection on the parasite population needs to be
determined. The potential for such vaccine selection has already been demonstrated in the
field trial of an asexual blood-stage vaccine (Combination B) (Genton et al. 2002). The
combination B vaccine comprises of the merozoite surface protein MSP-l, the 3D7 allele of
..
MSP-2 and the ring infected erythrocyte surface antigen (RESA). In this field trial, selection
for infections that differed from the vaccine type occurred. During the follow up period it was
shown that vaccination reduced the prevalence of the 3D7 allele of MSP-2, but not the
alternate FC27 allele. Notably, previous studies suggest that this FC27 type allele results in
more virulent infections (Engelbrecht et al. 1995). To date, the main focus of concern has
centred on the problem of vaccine escape due to antigenic diversity (e.g. McLean 1995;
Carvalho et al. 2002; Ballou et al. 2004; Greenwood 2005; Targett 2(05). What is not clear
from this field trial is whether selection on the parasite population was caused by vaccine
escape due to immune specificity or whether the vaccine was less good at controlling more
virulent infections. It is feasible that a combination of both processes will occur, and as we
edge closer to a viable malaria vaccine it is becoming increasingly important to explore these
possible outcomes.
In the experiments described here, I tested the effect of genetic diversity at the AMA-l locus.
To do this, I sequenced the ama-J gene of seven clones (termed AD, Al, AQ, AS, AT, BC and
CB) to determine how they differed from the vaccine derived clone DK. Based on both the
sequence data and the virulence as described by Mackinnon & Read (1999a), I challenged
vaccinated mice with a subset of heterologous clones
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I found that vaccination provided general protection against weight loss and red blood cell
loss. Vaccination also reduced parasite densities in a strain specific manner. Protection against
the homologous challenge was significant but incomplete, with 50% of infections becoming
patent. Among the heterologous parasites I found increased vaccine efficacy against parasites
showing higher sequence similarity to the AMA-l vaccine sequence and higher vaccine
efficacy against the less virulent parasites.
3.3. Material and Methods
3.3.1. Parasites and Hosts
I studied eight genetically distinct P. chabaudi clones, denoted AD, AJ, AQ, AS, AT, BC, CB
and DK (also known as 556KA). These isolates were originally collected from Thamnomys
rutilans in the Central African Republic in 1969 and 1970, cloned as described by Mackinnon
and Read (1999a) and stored in liquid nitrogen until use.
Hosts were inbred female C57BU6JolaHsd mice aged 6-8weeks (Harlan England). They were
fed on 41B maintenance diet (Harlan UK) and their drinking water was supplemented with
0.05% para-amino benzoic acid to enhance parasite growth (Jacobs 1964) and kept in a 12L:
12D cycle.
3.3.2. Sequencing of the AMA-l alleles of P. chabaudi
Primers were designed to amplify the ama-J gene as two fragments. Primer sequences for
fragment 1 were: Forward 5'CITGGGTAAITGITCCGA3' and reverse 5'
GGITTCCCAATCTTCACG3' . Primer sequences for fragment 2 were: Forward 5'
GGGTCCAAGATATGTAG 3' and reverse 5' TGGTGITGTGTGTGATGC3'. DNA was
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amplified by PCR using Immolase™ DNA polymerase (Bioline). Sequencing reactions were
...
performed using a Prism BigDye Terminator Cycle Sequence Kit Version 3.1 (ABI) and the
University of Edinburgh SBS Sequencing Service ran the products of the reactions in-house
on an ABI 3730 capillary sequencer. Sequences were analysed using DNAstar.
3.3.3. Experimental Design and Procedure
This experiment was performed as three experimental blocks (Table 3.1). In blocks 1 and 2,
vaccinated and unvaccinated control mice were separated into 5 groups to be challenged with
one of four heterologous strains AQ196,ASII946, BC208, and CB1106or with the homologous
strain DK106.These five parasite clones were chosen out of the eight parasite clones sequenced
due to their pre-determined virulence phenotype and by their sequence diversity. The parasite
clones AQ, AS and BC (known to be of similar virulence) were shown to differ in their
sequence similarity to the vaccine derived clone and were selected to test the role of genetic
diversity on vaccine efficacy. Parasite clones AS and CB were known to differ in virulence but
were shown have identical AMA-l protein sequence and were therefore chosen to determine
the role of virulence in vaccine efficacy. In experimental block 3, vaccinated and unvaccinated
control mice were challenged with either AS or CB to clarify the role of virulence in vaccine
efficacy.
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Table 3. 1. The experimental design, showing the number of mice used in each block and for each parasite clone .
...
parasite OK parasite AS parasiteCB parasiteBC parasiteAQ
control vaccine control vaccine control vaccine control vaccine control vaccine
Block1 3 3 3 3 3 3 4 4 3 3
Block2 8 5 8 5 8 5 8 5 8 5
Block3 - - 5 5 6 6 - - - -
11 8 16 13 17 14 12 9 11 8
3.3.4. Vaccination
In all experimental blocks, recombinant AMA-l derived from parasite clone DK was
emulsified in Montanide ISA 720 (Seppic, Paris). Mice were injected intraperitoneally with 10
ug of protein in a l00ul emulsion. Boost immunisations were conducted 4 weeks after the
primary immunisation. Control mice in experimental blocks 1 and 2, were injected with either
lOOul of PBS, or l00ul of PBS emulsified in Montanide ISA 720. In experimental block 3,
control mice were injected with l00ul PBS emulsified in Montanide ISA 720. The vaccination
protocol was adapted from Crewther et al. (1996).
3.3.5. Parasite challenge and sampling
All infections were initiated with an intra-peritoneal injection of lxl05 parasitised red blood
cells two weeks after the boost immunisation. Inoculations were prepared by diluting blood
from donor mice in a medium of (50% heat inactivated Calf Serum; 50% Ringer solution
[27mM KCL, 27mMCaCh and 0.15 M NaCl)], 20 units of heparin Iml mouse blood).
Daily sampling involved weighing mice to an accuracy of O.lg and estimating red blood cell
density by flow cytometery (Beckman Coulter). In experimental blocks 1 and 2, thin tail blood
smears were taken, fixed in methanol and stained in Giemsa to allow the counting of
parasitaemia (proportion of red blood cells infected) using microscopy. When parasitaemia
was high, I counted 500 red blood cells in at least four microscopic fields. With lower
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parasitaemias I counted at least 20 microscopic fields (corresponding to at least 10 000 red
...
blood cells), and calculated the average number of cells per field. Parasite density was
calculated as the product of the parasitaemia and the red blood cell density. In experimental
block 1, mice were sampled every day from day 3 to day 16 post infection (PI), while in
experimental block 2 mice were sampled every day from day 3 to day 21 and then days 23 and
25 PI.
-
In experiment 3, the parasite density was determined by quantitative PCR (Cheesman et al.
2003; Bell et al. 2006). Five #Llsamples of tail blood were collected into citrate saline every
day from day 3 to day 21 and then days 23 and 25 PI. On the day of collection, samples were
centrifuged at 13, 000 r.p.m, the supernatant removed and the pellet stored at -70°C for
subsequent DNA extraction using Instagene Matric (BioRad.) Real time PCR cannot
distinguish between asexual and gametocytes, however the relative density of gametocytes to
asexual parasites is typically so low «1 %) that they do not affect the analysis or conclusions.
3.3.6. Trait definition and statistical analysis
Prior to analysis I defined and constructed the following summary traits to describe part of or
all of the infection. For measures of virulence I determined the maximum red blood cell loss
and maximum weight loss of the hosts from pre-inoculation levels (day -1). Maximum red
blood cell loss data was transformed using 10gIO(density) to meet normality and homogeneity
of variance assumptions. Mice that died were included in the analysis of maximum weight loss
and maximum red blood cell loss as it is assumed that they reached these maxima prior to
death.
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To calculate the numbers of parasites present during an infection, I calculated the area under
...
the parasite density curve. All experimental blocks were used to determine total parasite
densities during the acute phase of the infection, which occurs between days 3-16 post
infection (PI). Mice that died during the experiment were included in acute phase analysis as
all deaths occurred after the peak parasite density, and therefore after most of the acute phase
parasites have been produced. In experimental blocks 2 and 3, parasite densities during the
chronic phase (days 17- 25) were also calculated. Mice that died were not included in the
chronic phase analysis. All density data was transformed using [loglO (density +100)] to meet
normality and homogeneity of variance assumptions.
I analysed all traits using General Linear Models (JMP in 5.1), with the explanatory variables
being 'treatment', 'parasite clone' and where relevant 'experimental block'. Treatment had two
levels (vaccinated and control); parasite clone had five levels in experimental blocks 1 and 2
(AQ, AS, CB, BC, DK) and two levels in block 3 (AS and CB) and experimental block had
three levels (1, 2 and 3). For all the models I first fitted the maximal models and all two-way
interactions where relevant. I then minimized the models by removing non-significant terms (p
> 0.05), beginning with the highest-level interaction. As 'block' main effects are of little
biological interest in their own right, I reported them only if they interacted significantly with
the host-by-parasite interaction. Least square mean student t tests were used for pair-wise
comparisons if the treatment*parasite clone interaction was significant
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3.4. Results
3.4.1. Sequence diversity within the AMA-l region of P. chabaudi clones
When comparing the nucleotide sequence of the heterologous parasite clones to the vaccine
derived clone DK, I found AS (96.9%), BC (96.8%) and CB (96.9%) to be the most similar,
with parasite clone AQ (93.9%) being the least. Among the heterologous clones, BC differed
from AS and CB by one replacement mutation and AS and CB differed from each other by
one silent mutation. The protein sequences of the parasites AS, BC and CB each differed from
the protein sequence ofDK at 18 residues, while AQ differed from DK at 30 (Figure 3.1.).
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Figure 3.1. Multisequence protein alignment of AMA-l from the five parasite clones.
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3.4.2. Mortality
...
During the experiment, 16 out of 119 (13.4%) mice died after the peak parasite density of the
infection (Table 3.2.). Of these, 15 were infections with parasite clone CB, 10 of which were
naive hosts and 5 vaccinated. The other remaining death was in an unvaccinated host infected
with parasite clone BC.
Table 3.2. The number of mice that died during the experiment, for each block and parasite clone. The last row
gives the total number of mice that died per number infected.
parasite OK parasite AS parasite CB parasite BC parasiteAQ
control vaccine control vaccine control vaccine control vaccine control vaccine
Block1 0 0 0 0 3 1 0 0 0 0
Block2 0 0 0 0 1 1 1 0 0 0
Block3 - - 0 0 6 3 - - - -
TOTAL 0/11 0/8 0/16 0/13 10/17 5114 1/12 019 0/11 0/8
3.4.3. Virulence differences attributed to parasite clone, in naive hosts only
In experimental blocks 1 and 2, control mice inoculated with PBS and control mice inoculated
with PBS emulsified in montanide did not differ in red blood cell loss (treatment; F 1,45= 1.2,
p=O.27) or weight loss (treatment; F 1,45= 1.3, p=O.2). These mice were therefore combined as
a single control group.
Considering these control hosts only, differences in red blood cell loss, weight loss and host
survival were influenced by the infecting parasite clone (Figure 3.2. solid lines only: red blood
cell loss: F4, 59=5.6, p<O.OOI, weight loss: F4, 6(F9.5, p<O.OOI, survival: X2=23.4, df=4,
p<O.OOIrespectively). Hosts infected with parasite clone DK had less red blood cell loss than
the narve hosts infected with the other parasite clones as on its removal from the analysis,
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hosts infected with AS, BC, CB and AQ had similar levels of red blood cell loss (F3.49=0.67,
p=0.57).
Parasite clones AS, BC and AQ did not differ in weight loss (F2.36=0.9, p=0.38). Grouping
these three clones together and comparing them to parasite clone CB, I found CB infections to
be result in greater weight loss (Fl. 52=7.8, p=0.OO7). Parasite clone DK infections resulted in
less weight loss than CB infections and the grouped AS, AQ, BC infections (DK vs. CB: Fl.
24=26.9, p<O.OOOl,DK vs. AS,AQ,BC: Fl. 46=30.4, p<O.OOOl).Parasite clones could be ranked
from high to low virulence based on weight loss as: CB, (AS, AQ, BC), DK.
Specifically comparing parasite clones AS and CB, I found that unvaccinated hosts infected
with parasite clone CB lost more weight and were more likely to die than unvaccinated hosts
infected with AS (Fl. 26=8.4,p=0.OO7,X2=18.3 dfe l , p<O.OOlrespectively), although red blood
cell loss was similar between these two groups (Fl. 26=2.5,p=0.12).
3.4.4. Virulence through time
The daily weight change and red blood cell dynamics are illustrated in Figure 3.2. In both
vaccinated and control hosts, infections with parasite clone DK did not induce weight change,
however weight loss was observed in infections with parasite clones AS, CB, BC and AQ,
which was followed by a return to pre-infection levels. All mice apart from vaccinated hosts
infected with parasite DK had an initial reduction in red blood cell density, followed by a full
return to pre-infection levels.
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Figure 3.2. Daily weight change and red blood cell density (RBC) from pre-infection levels. The solid line
...
represents the unvaccinated hosts, while the dark dashed line represents the vaccinated. Each line represents the
mean weight change or RBC change (average across experimental block.± s.e.m.) of up to 17 mice. The grey
dashed line represents the pre infection weight and red blood cell density.
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3.4.5. Protective effect of vaccination on virulence
...
Vaccination provided protection against weight loss, with the level of protection the same
across all parasite clones (Figure 3.3a: treatment: Fl. 111=12.0,p<O.OOOI,treatment*parasite:
F4. 107=1.8,p=O.13). Vaccination also provided protection from red blood cell loss, with the
magnitude of this effect differing across parasite clones (Figure 3.3b: treatment*parasite: F4.
H)6=3.8,p=0.OO6).
In contrast, no protective effect of vaccination from death was determined (treatment; df =1
X2=1.98 p=0.16, treatment*parasite; df=4 X2=0.74 p=O.94). This may be due to the limited
amount of death observed in this experiment. Across all blocks, eleven out of sixty seven
(16.4%) unvaccinated hosts died compared to five out of forty two (11.9%) of vaccinated
hosts.
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Figure 3.3. Maximum change in weight and (a) and red blood cell (RBC) densities (b) for the five parasite clones
in naive and vaccinated hosts. The solid line represents the naive hosts, while the dashed line represents the
vaccinated. Each line is the maximum weight change or RBC change (least-squares mean ± SE from analysis) of
up to 17 mice.
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3.4.6. Parasite dynamics through time
The parasite kinetics are illustrated in Figures 3.4. All parasite infections followed similar
dynamics, with parasite density increasing until days 7-9, followed by clearance. In parasite
clones AS, CB and AQ, parasite density increases again in the chronic phase of the infection, a
phenomenon known as recrudescence.
Control mice inoculated with PBS and control mice inoculated with PBS emulsified in
..
montanide did not differ in acute phase density (treatment; F 1,44 = 1.3, p=0.26) or chronic
phase density (treatment; F 1,4S = 1.2, p=0.27) and were therefore combined as a single control
group.
During the acute phase, the anti-parasitic effect of vaccination differed among parasite clones
(Figure 3.4. treatment*parasite; F4, 109=25.3, p<O.OOI). Vaccination conferred protection
against hosts infected with the homologous parasite clone DK (DK vaccinated versus DK
control; t109=11.6,p<O.OOI)and the heterologous parasite clone AS (AS vaccinated versus AS
control; t109=2.7, p=O.004). Significant protection was not conferred against infections with
parasite clones CB (CB vaccinated versus CB control; t109=0.89,p=0.18), BC (BC vaccinated
versus BC control; t109=O.6,p=0.25) or AQ (AQ vaccinated versus AQ control; t109=O.38,
p=0.35). Note that least square mean student t tests were used for pair-wise comparisons. As
these comparisons are based on the least square means determined from the full model, the
degree's of freedom for these pair-wise tests equal the error degree's of freedom of the full
model.
~emoving the homologous parasite clone DK from the analysis, the effect of vaccination
varied among the heterologous parasite clones (treatment*parasite clone; F3, 92 =3.14,
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p=0.029). Comparing only the two parasite clones which had identical AMA-l protein
sequence but differed in virulence (AS vs. CB), I found that the level of protection marginally
differed, with the effect of vaccination greater against the less virulent clone
(treatment*parasite; Fl, S6 =3.7, p=O.057).
During the chronic phase of the infection, the anti-parasitic effect of vaccination varied across
parasite clone (Figure 3.7b: treatment*parasite; F4, 64=2.7, p=0.0381. Vaccination conferred
protection against hosts infected with the heterologous parasite clone AS (AS vaccinated
versus AS control; 164=3.2,p=0.OOO8),but not against infections with parasite clones DK (DK
vaccinated versus DK control; 164=0.2, p=OA), CB (CB vaccinated versus CB control;
164=0.08, p=0.46), BC (BC vaccinated versus BC control; 164=0.07, p=0.47) or AQ (AQ
vaccinated versus AQ control; 164=1.3,p=0.9).
Removing the homologous parasite clone DK from the analysis, the effect of vaccination
varied against the heterologous parasite clones (treatment*parasite clone; F3, S3 =3.5, p=O.02).
Comparing only the two parasite clones which were identical within AMA-l but differed in
virulence (AS vs. CB), I found that the level of protection differed, with the effect of
immunisation greater against the less virulent clone (treatment*parasite; Fr. 32 =6.96, p=0.013).
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Figure 3.4. Daily parasite densities for vaccinated and naive hosts challenged with different parasite clones. The
~
solid line represents the unvaccinated hosts. while the dashed line represents the vaccinated. Each line represents
the mean of each treatment group (averaged across experimental block ± s.e.m.) of up to 17 mice. DK is the
parasite clone from which the AMA-l vaccine was derived. Parasite clones AS. CB and BC all of which differed
from the DK AMA-l at 18 residues. followed by parasite clone AQ which differed at 30.
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Figure 3.5. Total parasite density during the (a) acute phase and (b) the chronic phase for the five parasite clones
in naive and vaccinated hosts. The solid line represents the naive hosts, while the dashed line represents the
vaccinated. Each line is the average total density (least-squares mean ± SE from analysis) of up to 17 mice.
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3.5. Discussion
I used the rodent malaria model system of P. chabaudi in laboratory mice to determine the
effect of parasite genetic diversity on the efficacy of a blood stage AMA-l vaccine. To do this,
I sequenced the ama-I gene of seven P. chabaudi clones and based on both their similarity to
the vaccine-derived parasite and their virulence, chose a subset for experimental infections. I
included three parasites of similar virulence but that differed in their genetic similarity at the
vaccine target and another pair identical at the vaccine target but differing in virulence. I found
that sequence diversity as well as other parasite factors were important in vaccine efficacy.
These other factors may be correlated with virulence.
Parasite clones AS, BC and CB were the most similar clones to the vaccine derived parasite
DK, differing at eighteen amino acid residues, while parasite clone AQ differed at thirty. I
found that protection was conferred against the homologous parasite type DK and
heterologous parasite AS, but not CB, BC and AQ. Comparing infections from parasite clones
AS and CB infections which are identical at the AMA-l vaccine target region but differ in
virulence, I found that that vaccinated hosts infected with the less virulent parasite AS had
lower parasite densities than the unvaccinated control. In contrast, parasite density did not
differ between vaccinated and unvaccinated hosts infected with the more virulent clone CB
(Figure 3.6a-b).
This experiment highlights the potential for anti-replication vaccines to act as agents of
selection. In particular, it emphasises that factors other than diversity at the target antigen can
influence vaccine efficacy. As noted above, the Combination B vaccine trial led to the
. selection of a more virulent variant (Genton et al. 2002). In this field trial it is not clear as to
whether the FC27 type parasites were maintained in the population due to their lack of
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similarity to the allele in the vaccine or some other factor such as parasite virulence. Similarly,
it is not clear from my experiments if protection was conferred against parasite clone DK due
to its 100% homology to the vaccine antigen or whether it arose due to the avirulent nature of
the parasite clone.
One explanation for the protection observed against the avirulent parasite AS, but not the more
virulent CB could be that virulent parasites are better able to be maintained in immune
environments. If true, this suggests that immune hosts could be more effective at selecting for
virulence than naive hosts. Evidence for such has previously been observed by Mackinnon &
Read (2004a), where clones of P. chabaudi were serially passaged through narve and semi
immune hosts. After passage, it was found that all lines had increase in virulence, but that this
increase was greater in semi-immune hosts.
It is therefore crucial to determine if a disproportional benefit of virulence exists in
vaccinated/immune environments. Using AMA-l vaccinated hosts I am continuing this work
on two fronts. In the first set of experiments, I am using serial passage to experimentally
evolve the parasite clone DK. Serial passage involves the transfer of parasites from one host to
another, often resulting in increased parasite virulence (Ebert 1998; Mackinnon & Read
2004a). This occurs as the parasite variant at the highest frequency in the transfer inoculum
(which we assume is the most virulent) has the selective advantage. The use of an ancestral
and passaged form of parasite clone DK will enable the infection of vaccinated hosts with
parasites that are identical at the vaccine target and similar at all other loci but differ in
virulence. To date, the serial passage of DK is continuing. A pilot study comparing the
ancestral and passaged DK parasites showed that after 15 transfers there was only a marginal
increase in virulence.
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In the second approach I have be using a virulent and avirulent form of parasite clone AS.
...
Both avirulent and virulent forms of the parasite clone AS are derived from a moderate clone
AS (for full details see: de Roode et al. 2005b). In brief, the avirulent form of AS was derived
through the drug selection of the moderate clone. The virulent parasite was then derived
through the serial passage of the avirulent form. To date, I have infected vaccinated and naive
hosts with the avirulent and virulent forms of the parasite clone AS. For reasons yet to be
determined, no protection against either form of the parasite clones was conferred to
..
vaccinated hosts. Due to this surprising result, I then sequenced the AMA-l target region for
both of forms of AS parasite and found them to be identical to the sequence of the clone AS
reported above, to which we find protection. As this suggests that the vaccinations may not
have induced immunity, this experiment is currently being repeated with ELISA performed
prior to parasite challenge to ensure an immune response has been stimulated.
To the best of my knowledge, the present and proposed experiments above would be some of
the first studies explicitly aimed at testing the role of virulence in vaccine efficacy. Previous
rodent and primate studies using recombinant vaccines and heterologous parasite challenge are
limited to homologous challenge and/or challenge with one or two heterologous parasites
(Burghaus et al. 1996; Crewther et al. 1996; Rotman et al. 1999; Sierra et al. 2003; Goschnick
et al. 2004; Dutta et al. 2005). In studies such as these it is often difficult to distinguish the role
of virulence and diversity at the target vaccine region, as the two factors are confounded due
to experimental design.
What my data highlights is that both diversity in the target region and other parasite factors are
.important in vaccine efficacy. Concerns about the strain specific nature of vaccines as well as
their immnuogenicity have led to advocacy of a multivalent, multistage vaccine strategy
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(Moore et al. 2002; Mahanty et al. 2003; Good 2005). My data supports the necessity of this
but also highlights that research into the other parasite factors such as virulence may be
important for the future of malaria vaccine efficacy.
Altering the immune level of a population through vaccination may have evolutionary
consequences. Increasing parasite virulence is one possible consequence. This could occur in
several ways, including 1) disproportionate vaccine efficacy against avirulent clones, (or the
immune breakthrough of virulent clones), as suggested by the results above; 2) the reduction
in the fitness costs to pathogen virulence and 3) the alteration of competitive interactions (next
chapter). As we move closer to a viable vaccine, it will become increasingly important to gain
an understanding into the selective effects of vaccination.
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4. The impact of immunity on competition in mixed genotype
infections.
4.1. Abstract
In naturally diverse Plasmodium populations, ecological interactions between parasites can
rapidly affect the evolution of important traits. Disease intervention strategies can also alter
these interactions. Malaria populations are frequently diverse and hosts may harbour either
single or mixed genotype infections. In Plasmodium chabaudi it has been shown that that this
diversity leads to competitive interactions that, in accord with much theory, competition can
lead to the evolution of virulence. Here, I used P. chabaudi to investigate whether the outcome
of this competition differs by immune environment. In particular I investigate whether host
immunity, generated by either vaccination or whole parasite challenge alters 1) the success of
an avirulent parasite in a mixed infection compared to in a single infection and, 2) the
frequency of this avirulent clone relative to that of a virulent clone when sharing a host. I
found that in one out of three experiments the immune environment altered competition,
however in all cases the outcome of within-host selection did not change.
4.2. Introduction
In naturally diverse Plasmodium populations, ecological interactions between parasites can
affect the evolution of parasite traits such as virulence. Central to this evolution is how well a
parasite transmits from one host to the next host. This will be influenced by many factors,
including whether a parasite ends up sharing a host and if so, with whom.
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Interactions between co-infecting genotype are likely to be important in the study of malaria as
Plasmodium infections commonly consist of more than one genotype (Babiker et al. 1999b;
Smith et al. 1999; Tanner et al. 1999; Babiker et al. 2000; Bruce et al. 2000; Jafari et al. 2004).
In human malaria there is indirect evidence for the presence of competition' between co-
infecting genotypes (Daubersies et al. 1996; Mercereau-Puijalon 1996; Arnot 1998; Smith et
al. 1999; Bruce et al. 2000), however due to ethical constraints and confounding variables
direct evidence of competition is difficult to find. Theory also suggests that interactions
..
between co-infecting genotype are likely to be important. If virulent genotypes are
competitively superior, mixed infections will select for increase virulence (Levin & Pimentel
1981; Bremermann & Pickering 1983; Ewald 1983; Bonhoeffer & Nowak 1994; Nowak &
May 1994; van Baalen & Sabelis 1995; Frank 1996; Mosquera & Adler 1998).
Experimental comparisons between single and mixed genotype infections are therefore
necessary. The use of Plasmodium chabaudi in laboratory mice is one model system where
this is feasible. The availability of a range of parasite clones with defined virulence
phenotypes and the ability to track specific genotypes in a mixed clone infections allows the
outcome of competitive interactions to be determined. To date, such studies have revealed that
avirulent parasites suffer more from competition than virulent parasites and that indeed
virulent parasites are competitively superior (Taylor et al. 1997; de Roode et al. 2003; de
Roode et al. 2004a; de Roode et al. 2004b; de Roode et al. 2oo5a; de Roode et al. 2oo5b; Bell
et al. 2006; Raberg et al. 2006). Both experimental data and theoretical predictions therefore
suggest that competition in mixed genotype malaria infections select for increased virulence .
. 2Competition is defined as an interaction between coinfecting strains, in which the population size of one strain is
depressed by the presence of the other strain. I use the term competition to include resource-based interactions,
direct attack, or reductions in clonal density by immune responses triggered by coinfecting clones (apparent
competition).
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Any intervention strategy that alters these competitive interactions could therefore affect the
evolution of virulence. Plasmodium intervention strategies are usually designed to act against
either the replicating stages or the transmission stages of the parasite. Interventions against the
replicating asexual stage, which include many potential vaccines, are aimed at easing the
suffering of an individual by reducing the parasite density of the infection. If this parasite
reduction coincides with a reduction in environmental space due, for example to an increase in
host immunity, competitive interactions could be enhanced, selecting for more virulent
genotypes. This scenario is also likely if virulent parasite clones are disproportionately better
at immune breakthrough than avirulent clones and this breakthrough further suppresses the
densities of the avirulent clones. In contrast, if vaccination increases the resources available
for co-infecting genotypes by, for example protecting the host from anaemia and increasing
available as red blood cells, competition could be reduced and selection for virulence lessened.
In principle, either outcome is possible.
To address these ideas empirically I undertook three experiments using P. chabaudi, to
determine if immunisation' altered 1) the extent of competitive suppression of the avirulent
parasite and, 2) the relative frequency of the avirulent clone in mixed clone infections.
In the first experiment, hosts were vaccinated with a candidate malaria vaccine antigen,
asexual blood stage antigen 1, AMA-l. In chapter 3, I determined the level of AMA-l
polymorphism across a range of P. chabaudi clones that differed in virulence. I found that
avirulent clone AS and virulent clone CB were identical to each other at the vaccine target, but
somewhat differed from the vaccine-derived antigen. Competing these clones in hosts
immunised with a single AMA-l antigen, I was thus able to determine the effect of a
3 In this thesis I use the terms immunise and immunisation to refer to the stimulation of the immune system by
either vaccination with a recombinant antigen or whole parasite immunisation.
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genotype-transcending immune environment. As natural immunity to malaria, as well some
malaria vaccines may have a strain specific component, hosts in experiment 2 were immunised
with live parasites clones known to generate strain specific immune responses. This was
complemented by a third experiment where I immunised with live parasites, from clones
where no strain specific immune responses have been observed. This approach allowed me to
explore how different immune environments may affect competitive interactions, and how this
impacts the evolution of parasite virulence.
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4.3. Materials and methods
...
4.3.1. Parasites and hosts
Table 4.1, summarises the experimental treatments of each experiment. In experiments 1 and
2, we used two genetically distinct P. chabaudi clones, denoted AS (pyrlA) and CB. AS
(pyrlA) was derived through pyrimethamine selection from clone AS (Walliker et al. 1975)
For simplicity AS (pyrlA) will be referred to as AS from here on. Clones AS and CB were
chosen for experiment 2 as in previous experiments these two clones have been shown to
induce strain specific immunity against each other (Jarra & Brown 1989; Snounou et al. 1989).
This means that after infection with parasite clone AS followed by drug treatment, the parasite
density of a subsequent infection with AS is reduced compared to a subsequent infection with
CB and visa versa. In addition, parasite clones AS and CB are identical within the AMA-l
region (Chapter 3). In experiment 3, we used the P. chabaudi clone AS (as above), as well as
the parasite clone AJ. Clones AS and AJ were chosen as they have previously been shown to
induce strain transcending immunity, such that immunisation with AS results in a comparable
reduction in subsequent infections with AS and AJ, and visa versa (SJ. Cheesman, pers.
comm.). All clones were derived from wild-caught thicket rats from the Central African
Republic (Beale et ai, 1978)
In all experiments, hosts were eight-week-old C57BU6J inbred female mice fed on 41B
maintenance diet (Harlan, UK). Their drinking water was supplemented with 0.05% para-
amino benzoic acid to enhance parasite growth (Jacobs 1964) and they were kept in a 12L:
12D cycle.
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Table 4.1. Experimental design and sample sizes. In experiment 1, immunisation involved inoculation of
~
recombinant AMA-I antigen in adjuvant, with a boost four weeks later. Control groups received only adjuvant at
both time points. In experiments 2 and 3, immunisation involved infection with live parasites or uninfected red
cells (controls), with drug cure four days later. Mice were euthanised at predetermined levels of morbidity.
Treatments Immunisation Parasite Number of Number of
challenge mice deaths
experiment 1 1 OK antigen+adjuvant AS 5 0
Recombinant antigen 2 OK antigen+adjuvant CB 6 3
immunisation 3 OK antigen+adjuvant AS+CB 6 1
4 Adjuvant AS 5 1
5 ,. Adjuvant CB 6 6
6 Adjuvant AS+CB 6 6
Experiment 2 1 nalve AS 4 0
Live parasite 2 naive AS+CB 5 0
immunisation 3 AS AS 4 0
4 AS AS+CB 4 0
5 CB AS+CB 5 0
experiment 3 1 nalve AS 5 0
Live parasite 2 naive AS+AJ 5 0
immunisation 3 AS AS 5 0
4 AS AS+AJ 5 0
5 AJ AS 5 0
6 AJ AS+AJ 5 0
7 AS+AJ AS 4 0
8 AS+AJ AS+AJ 4 0
Total 94 17
4.3.2. Stimulation of immune response
In experiment 1 (Table 4.1), refolded and reduced AMA-l derived from parasite clone DK
was emulsified in Montanide ISA 720 (Seppic). Mice were injected intraperitoneally with 10
ug of protein in a 100ul emulsion. Boost immunisations were conducted 4 weeks after the
primary immunisation. Control mice were injected with 100ul PBS emulsified in Montanide
ISA 720. This protocol was adapted from Anders et al. (1998).
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In experiments 2 and 3 (Table 4.1), mice were injected a dose of 104 parasites of either AS,
CB, AJ or AS+AJ, followed by drug treatment. The immunising dose of parasites was
prepared from infected red blood cells from donor mice. Thin blood smears and red blood cell
counts were used to determine the parasite densities (flow cytometry; Beckman Coulter).
Blood from these donor mice was diluted in calf serum solution (SO% heat inactivated calf
serum, SO%ringer solution [27mM KCI, 27 mM CaCh, O.ISM NaCI), 20 units of heparin per
mouse). Four days after infection, all the mice were dosed orally with 20mg/kg mefloquine
using a lubricated catheter. This procedure was repeated over the next two days. Previous
studies have shown that this protocol results in semi-immunity (Buckling & Read 2001;
Mackinnon & Read 2003, 2004a). Thin blood smears were taken to ensure that the treatment
had cleared the infection. Control mice received 104 red blood cells from a nerve hosts,
followed by mefloquine as above.
4.3.3. Experimental design and inoculation of mice with parasites.
Experiment 1 (Table 4.1): Two weeks after vaccination or sham injection, mice were
separated into 3 groups and challenged with either AS alone, CB alone or a mixture of AS +
CB. Mice infected with a single parasite clone received 10 5 parasites, whereas mice infected
with both clones received 2 x 105 parasites made up of 105 of each. Although mice infected
with both clones received double the dose of parasites compared to the controls, we know
from previous work that a two-fold difference in parasites numbers has a negligible effect on
parasite dynamics and virulence (Timms et al. 2001)
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Experiment 2 (Table 4.1): Four weeks after immunisation mice were challenged with 106
~
parasites of either AS alone, CB alone or a mixture of 106 AS+106 CB.
Experiment 3 (Table 4.1): Four weeks after immunisation mice were challenged with 106
parasites of either AS alone, AJ alone or a mixture of 106AS+ 106AJ.
For all experiments, inoculations were prepared from donor mice by diluting blood in calf
serum solution (50% heat inactivated calf serum, 50% ringer solution [27mM KCI, 27 mM
CaCh, 0.15M NaCl], 20 units "of heparin per mouse). Each mouse was injected
intraperitoneally, with a volume ofO.lml.
4.3.4. Monitoring of individual clones in mixed infections
In all experiments, individual clones in mixed infections were monitored by collecting 5 ul
samples of tail blood into citrate saline. After 1 min centrifugation at 13, 000 r.p.m, we
removed the supernatant and stored the pelleted blood at -70C for subsequent DNA extraction
using Instagene Matric (BioRad). We used real time quantitative PCR to measure the DNA
concentration of both clones in these samples (Cheesman et al. 2003) with primers as in Bell
et al. (2006). The real time protocols cannot distinguish between asexual and gametocytes and
so they estimated the densities of all parasites. In the data analyses we treated these estimates
as asexual density.
4.3.5. Trait definition and statistical analysis
As I am ultimately concern about the evolution of virulence, I focused my experimental design
and analyses on being able to determine competitive effects on the avirulent clone. If
competition is occurring, the parasite density of the avirulent clone in a mixed clone infection
would be lower than the parasite density of the avirulent clone in a single infections. In all
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experiments, the parasite density of the avirulent clone (clone AS) was therefore used as the
response variable in the statistical analyses. Due to the 24 hour cycle of Plasmodium
chabaudi, daily parasite counts allow the quantification of all of the parasites present. All
density data was transformed using [lOgIO(density +10)] to meet normality and homogeneity
of variance assumptions. All analyses were performed as repeated measures using PROC
MIXED in SAS 8.2 (SAS Institute 1999) with the repeated statement (subject = mouse) and
the Satterthwaite approximation of the denominator DF. For all the models I first fitted the
maximal models including and all' two and three-way interactions. I then minimized the
models by removing non-significant terms (p > 0.05), beginning with the highest-level
interaction. In no cases were any of the three-way interactions significant, so we do not report
them. The main effect of 'day', as well all two-way interactions with 'day' are not reported as
the well known dynamic kinetics of malaria infections are not the focus of this study.
Complementing all of the repeated measures analyses, we also analysed total parasite
densities. Total parasite densities are calculated as the sum of the parasite densities between
days 4-20. Analysis was completed using General Linear Models (JMP in 5.1).
4.3.6. Immunisation and competition
To investigate if the extent of competition was influenced by immunisation I compared the
parasite density of the avirulent clone (clone AS) in single and mixed clone infections, in
immunised and non-immunised environments. The effect of immunisation (immunised or not
immunised), multiplicity (single or mixed clone infection) and an immunisation-by-
multiplicity interaction on the parasite density of the avirulent clone was determined using
repeated measures analysis. If competition is either enhanced or alleviated in the immunised
hosts.there would be a significant interaction between immunisation and multiplicity.
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To investigate if the extent of competition was influenced by the genotype of the clone(s) used
in the live parasite immunisations, we also analysed immune animals only to determine the
role of genotype specificity (immunising clone-by-multiplicity). Due to the lack of treatment
group AS-alone in CB hosts (see table 4.1), we can only look at the effect of immunising
clone in Experiment 3.
4.3.7. Immunisation and within-host selection
To determine if the relative frequency of the avirulent clone (AS) was affected by
immunisation, we compared the relative density of AS to its competing clone, in the naive,
vaccinated and immunised animals. All proportion data was transformed using asin(sqrt), to
meet normality and homogeneity of variance assumptions. All analyses were performed as
repeated measures using PROC MIXED in SAS 8.2 (SAS Institute 1999) with the repeated
statement (subject = mouse) and the Satterthwaite approximation of the denominator DF. The
main effects were vaccination or immunisation, day and their interactions. To investigate if the
proportion of AS was influenced by the genotype of the clone(s) used in the immunisations,
we then analysed immune animals only.
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4.4 Results
...
4.4.1. Immunisation and competition
4.4.1.1. Experiment 1: Vaccine-induced immunity (AS and CB)
During the experiment, 17 out of 34 mice died after their peak parasite density (Table 4.1). Of
these, nine were infected with parasite clone CB, three of which were vaccinated and six
naive. Infections of AS+CB resulted in seven deaths, with one in a vaccinated host and the
remaining six others in naive, The remaining death was in a naive host infected with parasite
clone AS. This last death was highly uncharacteristic and as the mouse also had an atypically
low parasite density it was removed from further analysis. High levels of mortality were
observed in this experiment. We can offer no definitive reasons for these high levels apart
from potential quality differences in the hosts. Due to this, mortality repeated measures
analysis and total parasite density were only completed up to day 11 for this experiment.
In addition, two of the five vaccinated hosts infected with the less virulent parasite clone AS
had extremely low level parasite densities (maximum of 2 x 104 parasitesJul), compared to the
remaining three (maximum of 2 x 106 parasites/ul). To provide a conservative analysis, we
therefore report the following results with their inclusion and exclusion.
The parasite density of clone AS in single and mixed infections, in different immune
environments is shown in Figure 4.1a-c. Repeated-measures analysis including the two low
level infections showed that vaccination reduced parasite densities (Figures 4.1a, b, d:
vaccination: F1,3l.J =7.3, p=O.OI). The parasite density of the avirulent clone in single
infections did not differ from the parasite density of the avirulent infection in the mixed clone
infection, indicating that competition in the mixed clone infections was not occurring
(multiplicity: F1,29.6 =0.22, p=O.64). The multiplicity-by-vaccination interaction was also not
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significant (Table 4.2). Removing the two mice with low level infections, we found that the
parasite density of clone AS was reduced by both vaccination and competition and that these
effects were not interacting (Table 4.2, Figure 4.la,c,e: vaccine*day; F7,87.1=6.1, p<O.OOOI,
multiplicity; FI, 23=4.5, p=O.045). In vaccinated and naive hosts, competition reduced the total
parasite density by 44% and 40% respectively. Due to the death of naive hosts infected with
AS and CB, it was not possible to test whether competition was affected by vaccination
beyond day II. However, among vaccinated hosts only, there was no evidence of
-'
competition, when either including or excluding the low level infections (Figures 4.lb,c: FI,
10.3=0.03,p=O.85, FI, 7.9=0.2,p=0.66, respectively).
The parasite density of the more virulent parasite clone CB was reduced by vaccination, but
not by competition such that, the parasite density of clone CB was the same in single and
mixed clone infections (vaccination: F7, 26.9=7.9, p=0.OO9, multiplicity; FI, 26.4=2.3,p=O.14,
vaccination*multiplicity; FI, 25.4= 1.5, p=O.22).
Thus, we found no evidenced that vaccination enhanced or alleviated competition.
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Figure 4.1
Parasite density of parasite clone AS over time. Graphs compare the avirulent parasite clone AS in single and
mixed clone infections in (a) narve hosts (b) vaccinated hosts including two low level infections and (c)
vaccinated hosts excluding the low level infections. The solid line represents clone AS when alone in the host,
while the dashed line shows clone AS when in a mixed clone infection. The magnitude of competition is the
difference between the solid and dashed line. Plotted points are the average parasite density (least-squares mean ±
SE from analysis) of up to 6 mice.
Total parasite density of clone AS is shown in (d) including the two low level infections and (e) excluding the
two low level infections. The solid line represents the difference between clone AS when alone in narve and
vaccinated hosts. The dashed line shows the difference between clone AS when in mixed infections, in naive and
vaccinated hosts. The difference between the solid and the dashed line indicates the magnitude of competition.
Plotted points are the average total parasite density (least-squares mean ± SE from analysis) of up to 6 mice.
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4.4.1.2. Experiment 2: Live parasite immunisation 2 (AS and CB).
...
The density of the avirulent parasite clone AS in single and mixed clone infections, in naive
and immune environments is shown in Figure 4.2a-b. Repeated-measures analysis showed that
immunised hosts had lower parasite densities than na'ive hosts (Table 4.2, Figures 4.2a,b,c:
immunisation; Fl. 51.4 =143.5, p<O.OOOI). The parasite density of the avirulent clone AS, did
not differ between single and mixed clones infections indicating that competition in the mixed
infection did not occur (Table 4.2, Figures 4.2a,b,c: multiplicity; Fl. 54.5 =0.83, p=0.36,).
As we were unable to detect competition during the entire infection, we examined the acute
and chronic phases of the infection separately. During the acute phase, competitive
suppression of clone AS was occurring, with the magnitude of this effect the same in both
naive and immunised hosts (Figure 4.2d: multiplicity; Fl. 36.3 =5.4, p=0.028,
multiplicity*immunity; Fl. 34.5 =0.94, p=0.34, respectively). During the chronic phase, no
effect of competition was observed (4.2e: multiplicity: Fl. 34 =0.26, p=O.6,
competition*immunity; Fl. 30.9 =0.8, p=0.37, respectively)
Thus competition was neither enhanced nor alleviated by prior immunisation with live
parasites.
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Figure 4.2.
Parasite density of clone AS over time in (a) naive hosts or (b) host made immune through live parasite
immunisation. The solid line represents clone AS when alone in the host, while the dashed line shows clone AS
when in a mixed infection. The magnitude of competition is the difference between the solid and dashed line.
Plotted points are the average parasite density (least-squares mean ± SE from analysis) of up to 5 mice.
Total parasite density of clone AS in natve and immunised hosts, in single and mixed clone infections (c) during
the entire infection, (d) during the acute phase and (e) and during the chronic phase. The solid line represents the
difference between clone AS when alone in naive and immunised hosts. The dashed line shows the difference
between clone AS when in competition in naive and immunised hosts. The difference between the solid and the
dashed line indicates the magnitude of competition. Plotted points are the average total parasite density (least-
squares mean ± SE from analysis) of up to 5 mice.
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4.4.1.3. Experiment 3: Live parasite immunisation 1 (AS and AJ)
...
Figure 4.3a and b illustrate the density of parasite clone AS in single and mixed clone
infections, in naive and immune environments. Repeated-measures analysis showed that
competition and immunity were interacting, such that competition was alleviated in
immunised hosts (Table 4.2). Overall, competition reduced the density of AS in nai've and
immune mice by 65% and 40 % respectively (Figure 4.3c).
Considering immune hosts only,' we found that the parasite density of clone AS was
influenced by the presence of the coinfecting clone, but was not affected by the genotype of
the immunising clone (Figure 4.4: multiplicity; FI,42.4=5.3, p=0.026, immunising clone; F2,42.4
=1.1, p=0.35, respectively). The level of competition was the same in all of the immune hosts
(Table 4.2).
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Figure 4.3. Parasite density of clone AS over time in (a) naive hosts or (b) host made immune through live
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parasite immunisation. The solid line represents clone AS when alone in the host, while the dashed line shows
clone AS when in a mixed infection. The magnitude of competition is the difference between the solid and
mice.
dashed line. Plotted points are the average parasite density (least-squares mean ± SE from analysis) of up to 5
The total parasite density of clone AS in narve and immunised hosts, in single and mixed clone infections (c) The
solid line represents the difference between clone AS when alone in narve and immunised hosts. The dashed line
shows the difference between clone AS when ina mixed infection, in narve and immunised hosts. The difference
between the solid and the dashed line indicates the magnitude of competition. Plotted points are the average total
parasite density (least-squares mean ± SE from analysis) of up to 5 mice.
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Figure 4.4 Parasite density of clone AS in hosts immunised with parasite (a) AS, (b) AJ or (c) a mixture of both.
Plotted points are the average parasite density (least-squares mean ± SE from analysis) of up to 5 mice.
Total parasite density of the hosts immunised with parasite (a) AS, (b) AJ or (c) a mixture. Plotted points are the
average total parasite density (least-squares mean ± SE from analysis) of up to 5 mice.
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Table 4.2. Host immunity*competition interaction terms from repeated measures analysis and total parasite..
density analysis. In experiments 1 and 2, the lack of significant immunity*competitions interactions indicates that
the level of competition was the same in both the immunised/vaccinated and naive hosts. The alleviation of
competition was seen in Experiment 3, with an increase of the less virulent clone AS in the immunised hosts
compared to the narve.
Repeated measures Total parasite densJ!y_
Experiment 1(AS+CB) ..
vaccinated vs. naive, including all mice F1,28.9=0.05, p=0.8 Fl. 17=0.56, p=O.46
vaccinated vs. naive, excluding 2 low level infections Fl 21.2=1.1, p:0.31 Fl 15=0.92, p=O.35
Experiment 2 (AS+CB)
Immunised vs. nalve Fl50.B=0.1, p=0.76 Fl 19=0.39,p=0.33
Experiment 3 (AS+AJ)
Immunised vs. naive F,,7G.5 =6.6, p=O.01 F1,38=2.4,p=0.1
Immunised hosts only F2 40.1=1.0, p=O.35 F2 22 =1.2, p=0.29
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4.4.2. Immunisation and within-host selection
To determine if the relative frequency of the avirulent clone differed by immunisation, we
compared the relative densities of AS and its competing clone in the naive and immune
animals. Due the death of naive hosts infected with AS +CB in Experiment! and the lack of
immune mice with infections during the chronic phase in Experiment 2, we did this analysis
up to day 11 only (Table 4.3)
"
I found that in all experiments the frequency of AS in mixed infections did not differ between
the vaccinated and naive hosts (Figure 4.5, Table 4.4). Thus, there was no evidence that
immunisation affected the strength of within-host selection imposed by coinfection.
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Table 4.3
...
The number of mice that were parasite positive during the chronic phase of the infection after injection with a
mixed infection.
Experiment 1(AS+CB) Na"ive Vaccinated
n\a 2\5
Experiment 2 (AS+CB) Na"ive AS Immunisation CB Immunisation
5\5 0\4 1\5
Experiment 3 (AS+AJ) Na"ive AS Immunlsdatlon AJ Immunisation AS+AJ Immunisation
5\5 0\5 3\5 2\5
Table4.4
The F ratio and p value for the interaction term from the analysis of the proportion of AS in vaccinated!
immunised hosts versus narve hosts.
Acute phase (days 4-11) Chronic phase (days 12-20)
Experiment 1(AS+CB)
Fl 9=0.64, p=0.44 nla
Experiment 2 (AS+CB)
Immune vs. nalve F1.8.4=0.02, p=O. 89 nla
Immune hosts only Fl 64= 4.2, p=O. 08 nla
Experiment 3 (AS+AJ)
Immune vs. natve F1,27.S=2.8, p=0.1 Fl. 13.7=0.19, p=0.67
Immune hosts only F3 26.r1.6, p=0.2 F2 13.1=2.6, p=O.11
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Figure 4.5. Proportion of AS within a mixed clone infection in (a) naive and vaccinated hosts (Experiment 1)..
(b) immunised and naive hosts (Experiment 2). During the chronic phase of the infection only 1 immune host was
parasite positive. This mouse had been immunised with parasite clone CB and was parasite positive for the AS
clone only. This host is represented by the dashed dark grey line. (c) either AS or CB immunised hosts
(Experiment 2). The dashed dark grey line represents the CB immunised host, positive for parasite clone AS only,
as above. (d) immunised and naive hosts (Experiment 3) (d) either AS immunised, AJ immunised or AS+AJ
immunised hosts (Experiment 3). All hosts immunised with parasite clone AS were parasite negative for parasite
clone AS after day 10. In graphs (a), (b) and (d), the solid lines represent the average proportion of clone AS
when in naive hosts, while the dashed lines shows the proportion of clone AS when in vaccinated or immunised
hosts. In graphs (c) and (e), the dashed lines represent the average proportion of clone AS when in immunised
hosts, by immunising clone. The horizontal grey dashed line shows the frequency of 50%. Plotted points are the
average proportion of AS in a mixed infection (mean.± s.e.m.)
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4.5. Discussion
...
In this study, I undertook three experiments to determine if immunisation altered the extent of
competitive suppression and/or the relative frequency of avirulent clones in mixed infections.
In the first experiment, hosts were vaccinated with a candidate malaria vaccine antigen,
asexual blood stage antigen 1 (AMA-l). In experiment 2 and 3 hosts were immunised by live
parasite challenge. This approach allowed me to explore the effects of a genotype transcending
and genotype specific immune environments, as well as mimic recombinant vaccine induced
immunity (Experiment 1) and the more natural live parasite induced immunity (Experiment 2
and 3).
In all three experiments, I found that parasite clone AS reached lower densities in mixed
infections than in the single infections. Importantly, the magnitude of this competitive
suppression did not increase in any of the immunisation treatments. This suggests that
selection for increased virulence via competitive ability is not greater in immune
environments. This is seen most clearly in Experiment 1, where I found that in naive hosts, the
density of avirulent clone was reduced by 40% when in a mixed infection, while in vaccinated
hosts the reduction associated with the mixed infection was similar at 44%. Thus, mixed
infections were costly for the avirulent parasite clone, but this cost was the same in both naive
and vaccinated hosts. By contrast, in Experiment 3 competitive alleviation was observed. The
density of avirulent parasites was reduced by 65% in naive hosts, but in immune animals the
competitive suppression was only 40%.
However, although immunisation appeared to reduce the negative effects of competition on
the avirulent clone in Experiment 3, in no experiment did I find evidence that immunisation
enhanced the relative frequency of clone AS relative to its coinfecting clone (Figure 4.5).
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Specifically, when the relative success of the avirulent parasite in a mixed infection is
...
compared to its success when alone, immunisation appeared (in one experiment) to alleviate
competition. However, when the success of the avirulent parasite was directly compared to
that of a co-infecting virulent parasite, the virulent parasite was the better competitor in both
narve and immunised environments. This suggests that the virulent clone also benefited from
the alleviation of competitive effects caused by immunisation. This could not be tested directly
because logistical constraints meant that the relevant treatment groups could not be included in
the experimental design.
The extent to which clones suffer from competition is thought to be influenced by the specific
nature of the immune response. During the acute phase of the infection, it is generally
assumed that the immune response is largely non-specific, involving a general cellular
immune response (Taylor-Robinson 1995; Li et al. 2001) If so, when the immune system is
stimulated in a mixed genotype infection, all co-infecting clones will be affected. In contrast,
during the chronic phase of the infection it is thought that strain specific mechanisms are
involved (Jarra & Brown 1985; Phillips et al. 1997; Mota et al. 1998; Buckling & Read 2001).
More similar clones will have a greater impact on each other than clones that are controlled by
distinct immune responses.
Parasite clones AS and CB have been shown in previous studies to be relatively antigenically
distinct (Jarra & Brown 1989; Snounou et al. 1989); immunity elicited against parasite clone
AS is better able to clear an infection of parasite clone AS than CB and vice versa. In
contrast, parasite clones AS and AJ are thought to be antigenically similar with immune
responses directed against AS and AJ largely cross reactive (S.J. Cheesman, pers. comm.). In
my experiments, parasite densities during the chronic phase of infections, where strain specific
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immune responses would be expected, were dramatically reduced in immunised animals.
However, tentative evidence suggests that immunisation occurred in a strain-specific manner.
In experiment 2, only one out of the nine immunised hosts infected with a mixed infection was
parasite positive. This host had been immunised with the parasite clone CB and was positive
for the parasite clone AS; suggestive of CB specific immunity and in agreement with previous
observations. In addition, the possibility exists in that in Experiment 3, strain specific
immunity was observed with the combination of parasites thought not to elicit strain specific
responses: AJ parasites were preferentially removed from AS+AJ infections allowing a non-
significant increase of AS in these hosts (Figure 4.4 d). It is impossible to draw firm
conclusions from this data; however I speculate that immune specificity could indeed playa
role in competitive interactions during the chronic phase. If such specificity is elicited by
vaccination, it would be likely to reduce competition and thus weaken selection for virulence.
If tentative evidence for immune mediated competition during the chronic phase exists, is
there any evidence for immune mediated competition during the acute phase? In my
experiments, the overall lack of a significant immunity*competition interaction suggests not.
Previous experiments testing for immune mediated competition have led to contrasting results
(Raberg et al. 2006 and V. Barclay et al. pers. com. 2006). Raberg et al (2006) compared the
extent of competition in immunodeficient mice and immunocompetent mice. Immunodeficient
mice were 'nude' mice that have a recessive mutation that blocks the development of the
thymus. These mice have no mature T-cells and are unable to mount cell-mediated immune
responses or form most types of antibodies. Using these immunodeficient mice, it was found
that immune-mediated competitive suppression was occurring between days 10 -12, although
no overall effect could be detected during the acute phase. Barclay et al (2006) used a similar
approach where mice were antibody depleted of CD4+ T cells and single and mixed clone
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infections were compared in depleted and intact animals. In two separate experiments using
different combinations of competing clones, no evidence for immune mediated competition
during the acute phase was found. Together with my results, all these data suggest that for the
most part, the reduction in parasite density during the acute phase associated with competition
is caused by mechanisms other than immunity.
Once possible mechanism mediating the parasite density during the acute phase in mixed
,-
clone infections is resource based competition. As asexual P. chabaudi parasites require blood
glucose (Li et al. 200 1) and red blood cells to maintain replication, competition for glucose
and red blood cells seems feasible. Blood transfusion during and after the peak parasitaemia
has been shown to prolong P. chabaudi infection in mice (Yap & Stevenson 1994).
Competition experiments where resources are not limited will be necessary to determine if
such a mechanism is important.
These data support both theory and experimental data that mixed genotype infections select
for increased virulence, and shows that this process works in both narve and immune
environments. Importantly, I found no evidence that vaccination will further increase the
selection for virulence which arises in mixed infections. What this series of experiments do
not address is if virulent parasites are less readily cleared by vaccine induced immunity, the
subject of Chapter 3. Further experiments would be valuable given the expectation that
competition will affect virulence and that the direction of selection depends tightly on the
mechanism of competition.
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5. The effect of parental rearing conditions on offspring life history
in Anopheles stephens;
5.1. Abstract
The environmental conditions experienced by parents are increasingly recognised to impact
the success of offspring and to be of evolutionary significance. In this study, I tested for the
existence of parental effects in the medically relevant vector Anopheles stephensi. By varying
the larval parental environment and measuring key life history traits of their offspring, I found
that the parental effects did not influence the time taken for offspring to emerge, offspring size
or offspring survival. Parental effects were influential in determining the fecundity of their
adult daughters. Daughters from parents reared in low food conditions produced larger egg
clutches than daughters from parents reared in high food. Offspring reared in low food
conditions took larger blood meals if their parents had also experienced a low food
environment. Mosquito control methods resulting in environmental modification of larval
habitat, as well as strategies involving the large scale rearing and release of genetically
modified or sterile males may benefit from an increased understanding of how parent and
offspring larval rearing conditions interact to alter mosquito ecology and evolution.
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5.2. Introduction
...
The success of an individual is dependent on genetic background, environmental conditions,
and interactions between these. One factor which is increasingly recognised to have a
profound impact on individual success is the environmental conditions experienced by their
parents (Kirkpatrick & Lande 1989; Bernardo 1996; Rossiter 1996; Mousseau & Fox 1998;
Wolf et al. 1998). Whilst parental effects have been demonstrated in a wide range of taxa (e.g.
Gilchrist & Huey 2001; Laurila et al. 2002; Reinhold 2002; Costa et al. 2003; Bateson et al.
2004; Fox et al. 2004; Andersen et al. 2005; Badyaev 2005; Benton et al. 2005; Jones &
Widemo 2005; Sadd et al. 2005; Marshall et al. 2006; Moret 2006; Pieters & Liess 2(06), it is
not yet clear when parental effects are non adaptive (passive) or when they are adaptive.
Passive effects arise when the parental environment generates a constraint on offspring life
history. For example, nutrient deprivation in mothers may result in less well-provisioned and
hence smaller offspring. By contrast, parental effects may be adaptive if parents can perceive
cues in their environment and adjust per offspring investment so as to optimise offspring
fitness. Maternal effects in the freshwater crustacean Daphnia are a classic example. Mothers
kept in poor conditions can for example alter offspring size, survival, fecundity or resistance to
parasites (e.g. Lynch 1983; Mitchell & Read 2005; Pieters & Liess 2006). In this system,
offspring are likely to find themselves in a similar environment to their mothers, so for
mothers in poor environments it may be in their best interest to increase per offspring
investment so that the few offspring they produce will have a greater chance of survival.
Anopheline mosquitoes (Diptera: Culicidae) are medically important vectors, responsible for
the transmission of many diseases including malaria, filariasis and several arbovirus diseases.
Mosquitoes are hemimetabolous insects whose eggs and larvae develop in freshwater
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environments, eventually pupating into terrestrial airborne adults. This metamorphic life cycle,
as well as the potential for female choice in oviposition site, means that mosquito larvae may
experience a different environment to that of their parents. Female preference studies indicate
that fecund mosquitoes choose oviposition sites based on many factors including the
presence/absence of conspecific instars (which may indicate high food levels), food sources,
mosquito content and the presence/absence of potential predators (Kiflawi et al. 2003;
Mokany & Shine 2003; Bond et al. 2005; Huang et al. 2005; Pates & Curtis 2005). Such
..
behaviour indicates that female mosquitoes have the ability to alter their offspring fitness
through behaviour and raises the question of whether anopheles parents may alter investment
in their offspring as well.
Despite the hope for large scale rearing and release of sterile males and genetically modified
mosquitoes for malaria control, the effects of Anopheles larval parental rearing experience on
offspring success are to the best of my knowledge unknown. Yet, central to the success of any
breeding and release strategy is the production of large numbers of mosquitoes that have a
fitness (which includes mating success) close to the wild population (Phillips 2001; Atkinson
& Michel 2002; Moreira et al. 2002; Benedict & Robinson 2003; Andreasen & Curtis 2005;
Ferguson et al. 2005; Helinski et al. 2006).
To determine the extent of non-behavioural parental effects on Anopheles fitness, I conducted
a fully factored cross experiment where anopheles larvae experienced either the same or
different rearing conditions to that experienced by their parents. After varying the parental
environment, the offspring fitness components of emergence time, size, survival, blood meal
size and fecundity were measured. As genetic and phenotypic variance is often greater in
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stressful environments, particular attention is paid to parental effects in offspring reared in low
food environments (reviewed in Hoffmann &Merila 1999; Danks 2006)
5.3. Materials and methods
5.3.1. Experimental design
Mosquitoes originated from a long-standing laboratory stock of Anopheles stephensi and were
reared under standard laboratory conditions at 27±2 °C, 70% humidity and in a 12: 12 light:
dark cycle. Eggs were hatched in 3 plastic trays (25cm x 25cm) filled with 1.5L of distilled
water. Two days after hatching, larvae from the three trays were mixed and 200 were
randomly transferred to 30 ml vials containing 5 mls of distilled water, where they were reared
individually (Figure 5.la). Half of these larvae were then randomly allocated to the low food
treatment group (lmg of Tetrafin food per day) and half to the high food treatment group (10
mg of Tetrafin food per day). When individuals pupated, their vial was covered with fine
nylon gauze until emergence. Appropriate food levels were determined from an earlier pilot
study and include the range where 100% emergence occurred. The position of the vials within
the insectory was fully randomised at this stage and in subsequent stages.
On emergence, the mosquitoes were pooled into three mesh cages (30 x 30 x 30 cm) per
treatments groups and provided with 10% glucose solution ad libitum (Figure 5.lb).
Approximately one week after emergence, one anaesthetised mouse was placed on each cage
from which the mosquitoes were allowed to feed for 20 minutes. One day later egg bowls
were introduced to the cage for oviposition.
These eggs were then pooled and hatched in 6 plastic trays for each treatment and 400
individual larvae (200) from each parental treatment group) randomly transferred to a standard
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vials as above (Figure S.lc). The larvae were allocated to either the high or low food treatment
groups (as above) and monitored daily for pupation. When individuals pupated, they were
transferred to a vial that was covered with fine nylon gauze and maintained without food for
survival analysis (Figure S.ld). On death, mosquitoes were transferred to a 1 ml tube and
refrigerated until the end of the experiment. At the end of the experiment the wings of each
mosquito were dissected and measured from the distal to dorsal points using microscopy.
This experiment was repeated eight weeks later. In the repeated experiment, offspring were
separated into two groups for either survival analysis as in the previous experiment, or for
fecundity analysis after a blood meal (Figure S.ld and e). Fecundity analysis involved
transferring both male and female offspring into mating cages (30 x 30 x 30 cm),with 4 mating
cages per offspring group. Five days after emergence, anaesthetised mice were placed on each
of the 16 mating cages and the mosquitoes allowed feed for 20 minutes. These mice had all
been infected 14 days before the feed with Plasmodium chabaudi, as the original intention was
to determine whether vectorial capacity was affected by parental environmental conditions.
However most unexpectedly on the day of the blood-meal, neither asexual nor sexual parasites
were present in any of the mice and on dissection of the female mosquitoes after egg-laying,
no transmission had occurred. As infected mice, were parasite negative on the day of the feed
and were randomly assigned treatment groups which were replicated, any treatment effect
should be unrelated to any effect of infection. Immediately after the feed, each female
mosquito was transferred to a clean vial covered with fine nylon gauze for 3 days to allow all
haematin (a by-product of decomposition of haemoglobin) to be excreted (Figure S.le), from
which blood meal size was estimated (Briegel 1980). Excreted haematin collected in the
bottom of the vial was dissolved in 1ml of 1% LiC03 solution. The absorbance of the resulting
mixture was read at 387nm in a spectrophotometer using LiC~ solution as a blank and
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compared with a standard curve made with porcine serum haematin (Sigma Aldrich).
Solutions that were within the error range of the Lie03 blanks (absorbance < 0.01) were
eliminated from the analysis and classified as non-feeders. After the 3-day haematin collection
period, mosquitoes were moved to new 30ml tubes containing 3mls of water to allow
oviposition (Figure 5.10.
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Figure 5.1.
...
The experimental set up. (a) In experiments 1 and 2, a total of 320 larvae were separated into the parental
treatments of high and low food, with individual larvae placed in a standard 30 m1 vial containing 5 mls of
distilled water. (b) After emergence, adult parents were transferred to a mating cage and kept in good conditions.
(c) Eggs from within treatment matings were split into high and low food. (d) In experiment 1, post emergence,
the offspring were starved and their survival determined. In experiment 2, half of each offspring treatment was
starve, while the other half was transferred to one of four mating cages for a blood meal. (e) After the blood meal
individual females were transferred to standard vials for haematin collection. (f) After haematin collection
individual females were transferred to standard vials for egg laying.
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5.3.2 Trait definition
The fitness components of emergence time, survival, adult size, blood meal size and fecundity
were measured. Both emergence time and survival were measured as the number of days
required for either a) the larvae to emerge as an adult, post hatching, or b) taken to die post
emergence. As an indicator of size, the length of one wing per mosquito from the distal to
dorsal points using microscopy was measured. Haematin mass was used as an indicator of
blood meal size, while fecundity was determined by counting the number of eggs laid over the
3 days following the blood meal.
5.3.3 Statistical analysis
The life history traits of emergence time and survival were analysed using Proportional
Hazards (JMP in 5.1). Adult size, blood meal size and fecundity were analysed using General
Linear Models. The explanatory variables were parental food (two levels), offspring food (two
levels), gender (two levels) and where relevant, experimental block (two levels). For all
models, a maximal model including all two and three-way interactions was fitted first. Models
were then minimized by removing non-significant terms beginning with the highest-level
interaction. In no cases were any of the three-way block*parent*offspring condition
interactions significant and these are therefore not reported. Significant block*parent or
block*offspring interactions did occur, but as they only reflected differences in magnitude
between blocks, they are not reported. For the blood meal analysis as well as the fecundity
analysis, the average blood meal size per replicate cage and the average number of eggs per
replicate cage were used as response variables (n=16), with average adult size as a covariate.
This is a conservative approach to deal with the issue of pseudo replication of treatments
arising from mosquitoes fed on the same mouse. I also tested for a main effect of mouse and
the interaction between mouse and the covariates (adult size and blood meal size). For both of
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the response variables of blood meal size and fecundity, the main effect of mouse and the
...
interactions were non-significant.
5.4. Results
5.4.1. Sample sizes
In experiment 1, 200 larvae were split into either a high food group or low food group, to form
the parental generation. Once adults, these parents were mated within groups (three per
treatment) and 400 eggs from the parental high food generation and 400 eggs from the
parental low food generation were used for the offspring experiments. Of these, complete
records of the emergence time, survival, gender and size were noted for 460 mosquitoes which
were included in the analysis. In the repeat experiment, 120 larvae formed the parental
generation, from which, 400 eggs from the parental high food generation and 400 eggs from
the parental low food generation were used for the offspring analysis. Of these, emergence
time was noted for 478 mosquitoes, with 140 of used in the survival trial and 287 used for
blood meal and fecundity analysis. Altogether, 149 females were included the fecundity trials
in which 19,844 eggs were counted.
5.4.2. Time taken to emerge
The time taken for larvae to emerge as adults post-hatching was determined by offspring food
conditions and to a lesser degree offspring gender (Figure 5.2a, table 5.2-1). Larvae reared in
high food conditions emerged from pupation up to 4 days earlier than larvae reared in low
food conditions and males emerged on average, one day before females. The food levels
experienced by the parental generation did not influence emergence time and this lack of
parental influence was constant across offspring food levels (Figure 5.2a, table 5.2-1).
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5.4.3. Size
...
Offspring larval food level was also the main factor influencing offspring adult size (Fig 5.2b,
table 5.2-2). Larvae emerging from high food conditions were on average 16% larger than
those emerging from low food conditions. Gender was also an important determinant of
offspring size, with females being 7% larger than males (Figure 5.2b, table 5.2-2). The larval
food levels of the parental generation did not influence offspring adult size (Figure 5.2b, table
5.2-2).
5.4.4. Survival
The food level experienced by the offspring was again the only factor found to be influencing
adult survival (Figure 5.2c, table 5.2-3a). As expected, offspring reared in high food
conditions survived for longer than offspring reared in low food conditions. Survival did not
differ between the males and the females and was unaffected by parental rearing conditions
(Figure 5.2c, table 5.2-3a). Larger offspring survive longer than smaller offspring (i = 148, df
=1, p=<O.OOOI),but offspring food level was still a major determinant of survival even when
controlling for offspring size (Figure 5.2c, table 5.2-3c).
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Figure 5.2
...
5.2a: Summary graphs showing the main effect of a) Offspring food (low and high) b) Gender (male and female)
c) Parental food (low and high) and the d) interaction between parent and offspring for the fitness components of
emergence time. Emergence time was measured as the number of days taken post hatching to emerge as an adult.
In total the emergence time of 938 mosquitoes was recorded. For this and all following analysis, 'block'
interactions were fitted. Each graph including those below, represents the least square means and the associated
standard error. Note that in some cases the dashed line is obscured by the solid line in the interaction graphs.
5.2b: Summary graphs showing the main effect of a) Offspring food b) Gender c) Parental food and the d)
interaction between parent and offspring for the fitness components of adult size. Adult size was determined from
the wing length of each mosquito. In total the wing length of 747 mosquitoes was recorded.
5.2c: Summary graphs showing the main effect of a) Offspring food b) Gender c) Parental food, and the d)
interaction between parent and offspring for the fitness components of adult survival. Adult survival was
determined as the number of days the mosquito remained alive, post hatching in the absence of water or glucose.
In total the wing length of 747 mosquitoes was recorded.
102
5.4.5 Blood feeding
...
Nineteen out of the 149 females that were given access to a blood meal were classified as non
feeders. Ten of these were parent low-offspring high, four were parental high - offspring low,
another four were parental low - offspring low and the one remaining female was parental
high - offspring high. No effect of parental food level, offspring food level or an interaction
between the two influenced female propensity to fed (parent: X2 = 2.8, df = I, p=0.09;
offspring: X2= 2.7, df e I, p=O.I; parent*offspring: X2= 2.5, df e l , p=O.I, respectively).
Of the 130 females that did feed, only their larval food level influenced blood meal size
(Figure 5.3a, table 5.2-4a). Daughters reared in high food conditions took 25% larger blood
meals than the daughters reared at low food conditions. Controlling for adult size, it was again
found that blood-meal size was influenced only by the food level experience of the offspring
(Figure 5.3a, table 5.2-4b). However, parental effects were apparent when the offspring reared
on low food only were considered: blood meal size was influenced by the larval food level of
parents, even when controlled for adult size (parent: F 1.6=27.4, p=0.OO2,parent controlled for
size: F 1.5=138.3, p<O.OOOI,respectively).
5.4.6 Egg number
Parental effects influenced offspring fecundity. Offspring of parents reared in low food
conditions produced more eggs than the offspring from parents reared in high food conditions
(Figure 5.3b, table 5.2-5a). Parental food level influenced offspring egg number, even when
controlling for offspring size (Figure 5.3b, table 5.2-5b). Considering the offspring reared on
low food only, I found that the fecundity of low food daughters was influenced by the larval
food level of their parents, even when controlled for adult size (F 1.6=13.6, p=O.OI, F 1.5=12.3,
p=0.017, respectively).
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Blood meal size and egg number were positively correlated, with larger blood meal sizes
resulting in increased egg production (F I. 14=34.1, p<O.OOOI).To determine the number of
eggs produced for a given blood meal size, I controlled for meal size and found that the
offspring as well as parental larval food level was influencing offspring fecundity (Figure
5.3b, table 5.2-5c). Parental effects were only influencing the daughters reared at low food
conditions and not daughters reared at high food (Fl. 5=16.1, p=0.01, F 1.5=4.5, p=0.09,
respectively). For the same size blood meal, the daughters reared at low food conditions were
20% more fecund if their parents had also been reared at low food levels.
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Figure 5.3
5.3a: Summary graphs showing the main effects of a) Offspring food and b) Parental food, as well as c) the
interaction between parent and offspring and d) the interaction between parent and offspring controlling for adult
size, for the fitness component of blood meal size. Haematin concentration was used as an indicator or blood
meal size. For each treatment lO-15 female mosquitoes fed on 4 replicate mice. The plotted points are therefore
the average blood meal size of each mosquito per mouse (n=16) and the associated standard error.
5.3b: Summary graphs showing the main effects of a) Offspring food and b) Parental food, as well as c) the
interaction between parent and offspring and d) the interaction between parent and offspring controlling for blood
meal size, for the fitness component of fecundity. Fecundity was determined by counting the number of eggs laid
over the 3 days following a blood meal. For each treatment lO-15 female mosquitoes fed on 4 replicate mice. The
associated standard error.
plotted points are therefore the average total number of eggs laid per mosquito per mouse (n=16) and the
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Table 5.1. The effects of parent food level, offspring food level and an interaction between them on the fitness
...
components of emergence time, adult size, survival, blood meal size and fecundity .... = < 0.05, ......= <0.01, *** = <
0.001, *** = <0.0001
Fitness Effects Test Statistic p Significance
component
1 Emergence
time Parental food [T = 2.7 0.09
(days) Offspring food [r= 699.7 <0.0001 ***
Sex [r= 41.4 <0.0001 ***
Parental*Off~i~ [T = 1.2 0.21
2 Size
(wing length) Parental food F1,593= 1.2 0.27
Offspring food F1,594=2567 <0.0001 ***
Sex F1,594=900 <0.0001 ***
Parental*Off~i~ ~= 0.7 0,39
3a Survival
(days) Parental food LT = 1.1 0,30
Offspring food er = 96.7 <0.0001 ***
Sex [r = 1.9 0.17
Parenta I*Offspring [] = 1.1 0.30
3b controlling Parental food r-r= 0.8 0,38
for adult size Offspring food rr = 62.9 <0.0001 ***
Sex iT = 1.6 0,20
Parental*Offsprlng [r = 1.6 0.20
4a Blood meal
size Parental food F1,13=3.29 0.09
(haematin) Offspring food F1,14=7.3 0.017 *
Parental*Offspring F1,12=0.8 0.39
4b controlling Parental food F1,12= 3.1 0.10
for adult size Offspring food F1,13= 6,9 0.02 *
Parental*Off~l~ &,u= 0.9 0.35
Sa Fecundity
(egg number) Parental food F1,14=6.7 0.02 *
Offspring food F1,13=3.2 0.096
Parental*Offsprlng F1,12=2.5 0.13
Sb controlling Parental food F1,13=5.9 0.03 *
for blood mea I Offspring food F1,12=3.0 0,1
size Parental*Offsprlng F1,1l=2.4 0.14
Se controlling Parental food F1,1l=16,7 0.0018 **
for adult size Offspring food F1,1l=8.0 0.016 *
Parental*Offspring F1,1l=5,6 0.037 *
Sd controlling for Parental food F1,lO=15.3 0,0029 **
~lIughters bloodmeal size Offspring food F1,lO=7.3 0.022 *
and adult size Parental*Offspring fuo_=5.2 0.046 *
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5.5. Discussion
This study sought to establish the role of parental effects on components of Anopheline fitness.
Key life history traits of emergence time, size, survival, blood meal size and fecundity were
measured. Parental environment had variable effects on mosquito fitness. Parental effects did
not influence the time taken for offspring to emerge, offspring size or survival. These traits
were heavily influenced by current offspring food levels only. There was a parental effect on
blood meal size, but this was only apparent in offspring reared in the low food environment.
This is consistent with previous studies where maternal effects were only identified in stressful
conditions (reviewed in Hoffmann & Merila 1999; Danks 2006). In my experiments,
daughters raised in the low food environment took larger blood meals if their parents had also
experienced low food than if their parents had experienced high food. Parental effects were
influential in determining the fecundity of their daughters. Daughters from parents reared in
low food conditions produced more eggs than daughters from parents reared in high food.
This effect of increased fecundity may have arisen as a facultative life history shift to
compensate for decreased longevity. A reduced adult lifespan of even a few days could
dramatically decrease total lifetime fecundity. In an environment where numerous bouts of
reproduction are not probable, the optimal strategy may be to shift resources into one or a few
larger reproductive efforts (Steams 1989). Measuring the survival of egg laying mothers,
lifetime reproductive success and egg quality would greatly aid the differentiation between
adaptive and passive effects. A key question to answer would be, does increased fecundity
come at the cost of reduced offspring or parental survival?
Does the potential for adaptive parental effects exist in this system? For this to be the case (i)
environmental variation would need to have the potential to reduce offspring fitness (ii)
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parents would need be able to predict their offspring's environment through reliable cues and
(iii) parents would be able to adaptively adjust the phenotype of their offspring to the
anticipated environment (Moret 2006). Evidence for environmental variation influencing
mosquito fitness is abundant. Temperature, humidity, parasitism, sugar feeding and plant
extracts have all been found to influence fecundity (e.g. Jahan & Hurd 1997; Jeyabalan et al.
2003; Mostowy & Foster 2004; Tripathi et al. 2004; Afrane et al. 2006). The potential for
prediction and life history adjustment are less clear. Oviposition preference indicates that
mothers can assess the environment their larval offspring will inhabit. However, it may be
quiet a bit harder for a female mosquito to predict the environment that her offspring will
inhabit, and I know of no direct evidence of such. There is much potential for work on
adaptive parental effects in Anopheles.
Whether the parental effects I report here are passive or adaptive, they have implications for
the success of disease control strategies. The ecological manipulation of larval habitats, as
well as the possible large scale release of captive raised genetically modified or sterile
Anopheles, makes the study of such effects relevant to future disease control. In the rearing
and release of hatchery salmon, it has been suggested that selection for increased fecundity has
resulted in decreased egg size which they linked to decreased survival (Heath et al. 2(03). In
the present study I have also shown parental effects on mosquito fecundity measures and
although assigning adaptive significance to this result is difficult, there is no doubt that rearing
conditions impacted a key life history trait. By its nature, captive breeding selects for quantity
over quality. If one lesson can be learned, it should be that large rearing in benign
environments may lead to their maladaptation to wild conditions.
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6. General discussion
...
Full discussions on specific findings have been provided within each chapter. Here I briefly
summarise my main findings, and then highlight general themes and future directions.
6.1. Findings
In this thesis I investigated selective pressures that could shape the ecology and evolution of
malaria and its Anopheles host. This is dependant on the intricate relationship between the
Plasmodium parasite, the human host and the Anopheles vector. Of particular interest were the
effects of disease interventions on these relationships.
In chapter 2, I explored the applicability of virulence trade-off theory to the rodent malaria
model system P. chabaudi: chapter 2 therefore forms the foundation for the rest of my thesis.
In virulence trade-off theory, virulence is an unavoidable consequence of a parasite's effort to
optimise its fitness, arising if parasites require extensive host exploitation to obtain
transmission to the next host (Anderson &May 1982; Sasaki & Iwasa 1991; Antia et al. 1994;
Ebert & Herre 1996; Read et al. 2002). An assumption of this theory is that virulence is a
parasite trait which is stable across host strain. Considering four host strains and four
genetically distinct parasite clones I found that virulence was indeed largely stable across all
host strains tested.
I next explored whether the candidate malaria vaccine AMA-l varied in efficacy against a
range of P. chabaudi clones and whether vaccination affects competitive interactions between
parasites. Malaria vaccines are being designed to target different stages of the parasite life
cycle. Anti replication vaccines, such as the one tested, target the stage of the life cycle
associated with morbidity and mortality. Theory suggests that anti replication vaccines may
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increase selection for parasite virulence. I found that diversity in the target antigen region as
...
well as other parasite factors were important in vaccine efficacy. This highlights the potential
for anti-replication vaccines to select against malaria parasites. Although mixed infections in
both naive and immune environments selected for increased virulence, vaccination did not
enhance or relieve this selective pressure.
Lastly, in chapter 5, I explored selection on the malaria parasite vector. Central for malaria
evolution is transmission to its vector. As Plasmodium evolution is intricately linked to vector
population dynamics, I explored environmental conditions that may influence Anopheles
fitness. Specifically, I investigated whether the larval food level Anopheles parents had
experienced, influenced the success of their offspring. I found that the fitness components of
emergence time, adult size and survival were influenced by offspring food levels. In contrast,
fecundity, and to a lesser degree, blood meal size, were influenced by parental food level. This
is to the best of my knowledge the first experimental evidence for trans generational effects in
Anopheles fitness.
6.2 General Themes: The use of animal models
The use of animal models assumes that certain key generalities exist. Consequently, animal
models have traditionally been a part of malaria research, and indeed have aided much of what
we know about the biology of malaria parasites. However, the ability to culture the human
malaria parasites in vitro, the availability of a number of Plasmodium genomes and differences
between human and in vivo model infections, raises questions as to whether there are still
benefits of using in vivo model systems.
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Plasmodium chabaudi in laboratory mice is one such in vivo system, where in addition to its
distance from the human malarias, the host and parasite are not a natural combination.
Typically differences between natural malaria infections and non-natural host parasite system
are numerous. For example, natural malaria infections do not often result in death, are thought
to be chronic and usually result in infections of low parasite density (reviewed in Landau &
Chabaud 1994) In contrast, non-natural malaria infections are usually short-lived, reach high
parasite densities and often result in host death (Stevenson et al. 1982).
And yet, the rodent model systems also share many feature with human malaria. For example:
• The basic biology of rodent and human parasites are similar. In particular,
Plasmodium chabaudi and Plasmodium Jalciparum both undergo synchronous
schizogony, capillary sequestration and have a preference for mature red blood
cells (Mons & Sinden 1990).
• Genome size, the number of chromosomes and the G+C content are similar
between rodent and human parasites (Carlton et al. 2002; Gardner et al. 2002;
Hall et al. 2005)
• Surface proteins are conserved between rodent and human parasites (Marshall
et al. 1989; Waters et al. 1990; Thompson et al. 2001; Janssen et al. 2002).
• The molecular basis of drug-sensitivity and resistance show are similar rodent
and human parasites (Carlton et al. 1998; Carlton et al. 2001; Walliker 2005).
In addition, the rodent malaria system enables in vivo investigations of parasite-host
interactions in well characterised host genetic backgrounds with a variety of parasite types. In
particular, the P. chabaudi system is the only malaria model with a range of genetically
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distinct parasite clones with distinct virulence phenotypes (Mackinnon & Read 1999a;
Ferguson & Read 2(02).
Enhancing the rodent-malaria model system will ensure its applicability in the future. One
exciting way forward would be to reconstruct mice with human immune systems or
genetically modify immune-intact mice to elicit human responses (Druilhe et al. 2002; de
Koning-Ward et al. 2003; Druilhe et al. 2005). One can image that these animals would be
better predictors of immunogenicity and would be useful in vaccine efficacy and safety
studies. With further advancement, this technology may even lead to the production of mice
able to maintain human malaria parasites (Cooke & CoppeI2004).
Above all, I see rodent malaria systems as a necessity for the study of virulence evolution.
Informative manipulations, such as those performed for this thesis, require experimental,
whole-organism infections to gain insight into the evolution of harmful parasites. Moreover,
the experiments required for the study of virulence in vertebrate hosts involve the comparison
of morbidity and the determination of parasite fitness, which for ethical reasons can not be
done in humans.
P. chabaudi in laboratory mice is therefore an ideal virulence model for any microparasite
where virulence is a parasite encoded trait and a virulence-transmission trade-off exists. An
added potential advantage of this system is that the non-natural host-parasite combination may
reveal more parasite genetic variation in the novel host environment; making it possible to
study virulence phenotypes that selection in natural systems would have otherwise removed.
This potentially allows the unique opportunity to study both evolutionary progression and
outcomes, as opposed to just the evolutionary outcomes evident in equilibrium systems.
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6.3. Future directions
1) Vaccines. One of the major caveats of this thesis is that it is based on a limited number of
parasite clones and only one candidate vaccine antigen. Further study using different parasite
clones and different candidate vaccine antigens are an obvious and desirable future direction.
The merozoite surface protein 1 (MSP-l) is one such antigen, thought to be largely conserved
in P.falciparum populations (Liance 1994; Collins & Paskewitz 1995; Phillips 2001; Reed et
al. 2006). If it is also largely conserved across P. chabaudi clones, the additional use of this
antigen would nicely contrast and complement the AMA-l experiments in Chapters 2 and 3.
2) Virulence Genes. To date vaccine escape has always been thought to result from antigenic
polymorphism (Crewther et al. 1996; Hodder et al. 2001; Mota et aJ. 2001; O'Donnell et al.
2001; Ekala et aJ. 2002; Healer et aJ. 2004; Polley et al. 2004; Cortes et al. 2005). However, in
chapter 3 I speculate that virulence may playa role in vaccine efficacy and I describe ongoing
experiments aimed at elucidating its role. The mechanisms underlying virulence are probably
complex, involving a large number of genes associated with parasite phenotypes such as cell
invasion, rosetting, cytoadherence and replication. Nonetheless, the discovery of genetic
markers for parasite virulence or the discovery of the genetic determinants themselves would
be highly desirable. If such discoveries were made, not only could virulence in the field be
tracked, but experiments involving 'virulence manipulated' parasite lines would allow firm
clarification of the role of virulence in vaccine efficacy (among other things) (Mackinnon &
Read 1999b)
3) Measuring Parasite Transmission. It would also be exciting to explore the assertion that
gametocyte density is positively associated with mosquito infection rate. Numerous other
studies have found that this is not always the case and that neither gametocyte patency
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(Boudin et al. 1993) nor density (Sattabongkot et al. 1991; Haji et al. 1996; Lensen et al. 1998)
are correlated with infection rates. This discrepancy may be due to variation in the
infectiousness of gametocytes throughout the life-span of an infection, such that a given
density of gametocytes gives rise to very different infection rates in mosquitoes depending on
the time point at which transmission is assessed (Dearsly et al. 1990; Butcher et al. 1996).
Given that the gametocyte infectiousness may vary throughout the course of a malaria
infection, the question arises as to how well gametocyte density on any particular day can
predict the lifetime transmission success of a malaria parasite. To compliment these studies it
would be of great interest to explore the infectiousness of vaccinated hosts versus naive hosts.
If immunity does indeed playa role in infectiousness, how does varying host immunity impact
on transmission? Resolving these questions is fundamental for evolutionary biologists in
order to evaluate whether it is possible to predict the selective advantage of particular parasite
genotypes from point surveys.
4) Mosquito Maternal Effects and Immunity. Lastly, an exciting extension to the present
work on parental effects in Anopheles, would be to study the role of maternal effects in
determining resistance to malaria. The ability of hosts to resist and control infection is like all
traits, dependant on the genotype, the environment and interaction between the two (Koella &
Sorensen 2002; Lambrechts et al. 2005; Lambrechts et al. 2006b). Initial experiments could
involve determining if maternal larval food level influences offspring infection rates. Trans-
generational immune priming has now also been shown in a range of invertebrates including
bumbles bees, daphnia and beetles (Carlier & Truyens 1995; Ravasi et al. 2002; Little et al.
2003; Sadd et al. 2005; Moret 2006). Understanding whether Anopheles mothers who
experience an environment of immune stimulation, produce offspring with up regulated
immune systems would greatly aid research into Anopheles resistance.
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With these experiments complete, it may be possible to finally draw finn conclusions
regarding the conditions that favour the evolution of virulence both generally and due to
intervention strategies such as vaccination. However, generalities will need to be approached
cautiously whilst data stems from only the malaria model system. In this regard, it is a
concern that much of the experimental work on the evolution of virulence is focused on so few
models systems. Ideally, this topic will, in the future be applied and tested in a many more
host-parasite system, such that general principles of the evolution of harm are illuminated.
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